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1.1    The Human Immunodeficiency Virus (HIV)
1.1.1 History and origin of the virus
The human immunodeficiency virus (HIV), a retrovirus belonging to the genus of
lentiviridae, is the causative agent of acquired immunodeficiency syndrome (AIDS).
The debate around the origin of HIV has sparked considerable interest and
controversy since the beginning of the epidemic. The first cases of AIDS occurred in
the USA in 1981, but they provided little information about the source of the disease.
On June 05, 1981, the Centers for Disease Control and Prevention in the United States
published the first report on an extremely rare form of pneumonia in five people
whose immune systems had been completely destroyed. Subsequently, science
progressed at a phenomenal rate. Within two years the virus responsible for the illness
was identified (Barre-Sinoussi et al., 1983) and later named HIV. By 1985,
serological screening was in place to prevent further infection through blood
transfusion and blood products. In 1986, clinical trials began on the first anti-HIV
drug, AZT (Zidovudine, a nucleoside reverse transcriptase inhibitor (NRTI)).
Unfortunately, disappointment followed as researchers realized that the virus was
capable of changing its genetic code with astonishing speed. The seven years that
followed were marked by discouragement, because the virus spread like wildfire
without a relief in sight. Then, at the 1993 International Conference on AIDS in
Berlin, the results of a clinical study combining two NRTIs ("bitherapy"), AZT and
ddC (Zalcitabine) or ddI (dideoxynosine), were presented, giving birth to renewed
hope. But once again, these treatments would prove insufficient. Finally, in early
1996, basic research on the biology of HIV resulted in the creation of a whole new
class of extremely powerful medications, inhibiting the function of a protein essential
for viral maturation (protease inhibitors). When combined with AZT and ddI
("tritherapy") (Richman, 2001), for example, these new medications yielded
spectacular results, which led to a 60% reduction of AIDS mortality in the United
States (Weiss, 2001).
By now, due to phylogenetic analyses it is generally accepted that the virus crossed
species in the first half to the 20th century. Human immunodeficiency virus-type 1
Introduction
9
(HIV-1), the most common cause of AIDS, is closely related to SIVcpz (simian
immunodeficiency virus) isolated from the chimpanzee subspecies Pan troglodytes.
Analogously, HIV-2, a less pathogenic strain (but still causing AIDS), is most closely
related to SIVsm from sooty mangabeys (Hahn et al., 2000). Additionally there is
geographical coincidence with the natural habitat of these primates and the areas of
HIV-1 and HIV-2 endemics respectively. One hypothesis to explain the outbreak of
AIDS is the direct exposure to infected animal blood (by hunting or other means),
which resulted in zoonotic transmission of SIVcpz and SIVsm to humans. This theory
is also supported by a study of David Ho and coworkers, who could isolate fragments
of an HIV-1 RNA in a patient serum sample (ZR59) drawn back in 1959 in Western
Africa (Zhu et al., 1998). This RNA sequence is fitting perfectly into the predictions
of the phylogenetic analyses and therefore supports with “hard data” this theory. The
particular social, economic, and behavioral changes that occurred in the early and
mid-20th century provided the circumstances whereby these viruses could expand and
reach epidemic proportions all over the world.
A competing hypothesis (Curtis, 1992; Hooper, 1999; Stricker and Elswood, 1997)
suggested that attenuated oral poliovirus (OPV) vaccination trials carried out in the
Belgian Congo in the late 1950s were responsible for the cross-species transmission of
SIVcpz that initiated the epidemic. These ideas rely on the assumption that
chimpanzee kidneys were used in vaccine preparation and therefore caused a direct
exposure of humans to infected matter. But two years later three independent
laboratories could not find any evidence to support this hypothesis (Berry et al., 2001;
Blancou et al., 2001; Rambaut et al., 2001). In none of the original vaccine vials
tested, SIV nucleic acids, which could have been responsible for a cross-species
transmission, were found.
1.1.2 Status quo of the epidemic
Despite being one of the best-studied pathogens during the last two decades, HIV
continues to spread over the world. It is estimated that some 6000 people are infected
on a daily basis. In Africa, the epidemic gives little sign of relief, in Asia it is
spreading, and in other regions of the world there is growing disquiet about the trends
being observed. The global HIV/AIDS epidemic killed more than 3 million people in
2003, and an estimated 5 million acquired the human immunodeficiency virus (HIV).
This is bringing the number of people living with the virus up to 40 million. Sub-
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Saharan Africa remains by far the region worst affected by the HIV/AIDS epidemic.
In 2003, an estimated 26.6 million people in this region were living with HIV,
including the 3.2 million who became infected during the past year. Countries in East
Asia and the Pacific are on the whole still keeping HIV at bay, with some 130,000
new infections this year. Overall, the two regions combined are estimated to have 6.4
million people living with HIV/AIDS and compared to Africa, infection rates in the
general population are still low.
In high-income countries it is estimated that 1.6 million people are living with HIV. A
total number of about 170,000 HIV infections have been reported in 17 countries of
Western Europe by the end of 2002. However, this number considerably understates
the cumulative number of HIV infections because the three countries with the most
extensive epidemics (France, Italy and Spain) do not yet have national HIV reporting
systems. In Germany about 2000 new infections and 600 deaths are recorded every
year. Due to widespread access to antiretroviral treatment the AIDS mortality
decreases and the total number of people living with HIV continues to rise in Western
Europe and the United States (WHO, 2003).
1.1.3 Retroviruses
Retroviruses comprise a large and diverse family of enveloped RNA viruses defined
by common taxonomic denominators that include structure, composition, and
replicative properties (Coffin, 1992). The virion RNA is 7-12 kb in size, it is linear,
single-stranded, nonsegmented, and of positive polarity. The hallmark of the family is
its unique replicative strategy, which includes as essential steps reverse transcription
of the virion RNA into linear double-stranded DNA and the subsequent integration of
this DNA into the genome of the cell. The discovery of this retroviral characteristic
had an important impact on our concept of genetic information, its molecular forms,
transmission, and evolution. In the early years of molecular biology, no exceptions to
the unidirectional and presumed irreversible flow of genetic information from DNA to
RNA to protein were known. This unidirectional flow came to be known as the
"Central Dogma." It was this Central Dogma that had to be revised when the
replication of retroviruses was understood (Baltimore, 1970; Temin and Mizutani,
1970). Furthermore, a significant percentage of the mammalian genome appears to be
the product of reverse transcription, containing sequences derived from ancient
retroviral integration.
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The reverse transcription of retroviruses is not a singular, odd exception but rather a
paradigm for a process that is shared by viral and nonviral genetic elements occurring
in yeast, Drosophila and eventually even in plants (Boeke and Chapman, 1991; Boeke
and Corces, 1989; Evgen'ev et al., 1992; Peterson-Burch et al., 2000). But the general
denotation of retoviruses comprises only the well-characterized forms in vertebrates.
They all have in common a virion of about 80-100 nm in diameter, enclosing two
single RNA strands by a complex of viral proteins (nucleocapsid). This capsid is by
itself enveloped by a lipid bilayer, derived from its host cell after budding, and
incorporates and displays specific viral proteins at the surface (Figure 1).
Figure 1: Schematic cross section through a retroviral particle
The viral envelope is formed by a cell-derived lipid bilayer into which proteins encoded by the env
region of the viral genome are inserted. These consist of the transmembrane (TM) and the surface (SU)
components linked together by disulfide bonds. Internal nonglycosylated structural proteins are
encoded by the gag region of the viral genome. They are the matrix (MA) protein, capsid (CA) protein,
and nucleocapsid (NC) protein. The suggested icosahedral structure of the retroviral capsid is not
definitely established. Major products of the pol-coding region are reverse transcriptase (RT) and
integrase (IN). The protease (PR) is derived from the pro gene between gag and pol (Coffin et al.;
Retroviruses (1997).
The retroviruses were originally classified by the morphology of the virion core as
visualized in the electron microscope and subdivided into seven groups (Table 1).
Five of these groups represent retroviruses with oncogenic potential (Oncoviridae),
the other two groups are Lentiviridae and Spumaviridae. Oncogenic retroviruses
occur in all classes of vertebrates, and many act as natural carcinogens (e.g.: Rous
sarcoma virus (RSV), Human T-cell leukemia virus (HTLV)). Lentiviruses are
causing disease principally by killing or inducing loss of function of specific cells and
tissues (e.g.: HIV). Relatively less is known about spumaviruses, which cause no
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known disease, and interest in this category is relatively recent. The prototypical
species is human foamy virus, a virus that has not been definitely linked to a specific
pathology. Furthermore, retroviruses are divided into two categories, simple and
complex, distinguishable by the organization of their genomes (Coffin, 1996; Murphy
et al., 1994). The simple viruses encode only the Gag, Pro, Pol and Env gene products
(described later) needed for the basic retroviral lifecycle. The complex viruses encode
the same gene products but also an array of regulatory and accessory proteins
necessary for an efficient viral propagation. All oncogenic members except the human
T-cell leukemia virus-bovine leukemia virus (HTLV-BLV) genus are simple
retroviruses. HTLV-BLV, lentiviruses and spumaviruses are complex.
Genus Example / Genome
1 Avian sarcoma and leukosis
viral group
Rous sarcoma virus (RSV); simple
2 Mammalian B-type viral group mouse mammary tumor virus
(MMTV); simple
3 Murine leukemia-related viral
group
Moloney murine leukemia virus
(MoMuLV); simple
4 Human T-cell leukemia bovine
leukemia viral
human T-cell leukemia virus; complex
5 D-type viral group Mason-Pfizer monkey virus (MPMV);
simple
6 Lentiviruses human / simian immunodeficiency
virus (HIV/SIV); complex
7 Spumaviruses human foamy virus (HFV); complex
Table 1: Classification of Retroviruses (Coffin et al.; Retroviruses (1997))
1.1.4 Genomic organization
The retroviral genomes are generally highly organized to have an optimal
compaction, with the least information necessary for their own survival and
propagation, on a minimal space. Retroviruses carry their genome as RNA but they
replicate via a DNA intermediate. The reverse transcription of the viral RNA genome
into a linear double stranded DNA form is the defining hallmark of retroviruses
(Gilboa et al., 1979; Temin and Mizutani, 1970). The course of reverse transcription
is complex and highly ordered, involving the initiation of DNA synthesis at precise
positions, and translocation of DNA intermediates that result in duplication of
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sequence blocks in the final product. The duplicated sequences are the long terminal
repeats (LTRs), flanking the newly synthesized DNA on both sides, and a central
stable 99 nucleotide-long plus strand overlap (the central DNA flap) (Charneau et al.,
1994). Existing models for the reverse transcription propose that two specialized
template switches known as strand-transfer reactions or “jumps” are required to
generate the LTRs, a mostly non-coding sequences with regulatory function during
reverse transcription and after provirus integration, and the central DNA flap, whose
function is still a matter of debate.
The viral genes gag, pro, pol, and env occupy the body of the DNA. gag encodes the
internal structural proteins of the virus. Gag (from the original name "group-specific
anti gen," reflecting what were believed to be the antigenic properties of this protein)
is proteolytically processed into the mature proteins MA (matrix), CA (capsid) and
NC (nucleocapsid). pol encodes the enzymes reverse transcriptase (RT), which
contains both DNA polymerase and associated RNase H activities, and integrase (IN).
pro encodes the viral protease (PR), which acts late in assembly of the viral particle to
process proteolytically the proteins encoded by gag, pro, and pol, and in some cases
also env. env encodes the surface (SU) glycoprotein and the transmembrane (TM)
protein of the virion, which form a complex that interacts specifically with cellular
receptor proteins. Although the order of the genes common to all retroviruses [gag,
pro, pol, and env] is invariant, the relationship of their reading frames is not. The gene
expression in retroviruses is equilibrated in a subtle way through reading frame shifts
and splicing (Hayward, 1977; Mellon and Duesberg, 1977; Weiss et al., 1977).
Accessory genes are located in a variety of places downstream from pol; they
commonly partially overlap env and U3 (a part of the LTR), as well as each other,
perhaps reflecting the evolutionary pressure implied by the limit to the size of an
RNA molecule that can be packaged into a virion. All accessory genes are expressed
from singly or multiply spliced RNAs (Figure 2).
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Figure 2: Genetic organization of generalized provirus
The proviral DNA as it is inserted into host DNA, with the long terminal repeats (LTRs) composed of
U3, R, and U5 elements at each end abutting cellular sequences. Sequences in the LTR that are
important for transcription, for example, enhancers, the promoter, and the poly(A) addition signal, are
marked. The gag, pro , pol, and env sequences are located invariably in the positions shown in all
retroviruses. Accessory genes are located as shown, and also overlapping env and U3 and each other,
and occasionally in other locations (Coffin et al.; Retroviruses (1997).
1.1.5 Virion proteins of HIV
Gag precursor
The Gag protein is the precursor to the internal structural proteins of all retroviruses.
Gag proteins must interact with each other, as well as with components in the plasma
membrane, the genomic RNA, and probably with Env proteins to direct the assembly
and budding of virions from the plasma membrane. Even in the absence of other viral
proteins, expression of Gag leads to budding of particles resembling real virions. In
wild-type viruses, Gag is cleaved late in the budding process by the viral protease
(PR) to yield the mature proteins MA, CA, and NC that are common to all retroviruses
as well as some other small proteins or peptides particular to the retrovirus species.
Because proteolytic cleavage occurs late in assembly, during or after the last stages of
budding, virions contain equimolar mixtures of the mature proteins. There are
approximately 1200 to 1800 molecules of each Gag protein in a virion, which
together represent about three quarters of the protein component of the virus (Craven
et al., 1991).
MA protein
In all retroviruses, the amino-terminal domain of Gag gives rise to the MA protein
(membrane-associated, or matrix) that builds a roughly spherical shell around the
viral core. The finding that most Gag protein precursors are modified by myristylation
at their amino termini provided a major clue to MA function (Henderson et al., 1983).
Myristate is a 14-carbon fatty acid that is added cotranslationally to many cellular
proteins associated with membranes (Grand, 1989). Mutagenesis of the myristylation
sites in MA leads to a block in the budding of particles and an accumulation of Gag
inside the cell. Hence this modification seems to be essential for retroviral assembly.
The three-dimensional structure of HIV-1 MA protein has been elucidated by nuclear
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magnetic resonance (NMR) (Massiah et al., 1994) and X-ray crystallography (Hill et
al., 1996). The lentiviral MA protein is trimeric in the crystal, with a globular amino-
terminal domain and a smaller carboxy-terminal domain projecting away. The
strongly positively charged regions on one side of each of the globular domains come
together to form a kind of platform that might connect the cytoplasmic tail of the
multimeric Env transmembrane complex to the MA protein shell. The MA protein
contains a nuclear localization sequence (Bukrinsky et al., 1993a) and has been found
to accompany the newly synthesized viral DNA into the nucleus (Bukrinsky et al.,
1993b). It is therefore possible that MA plays a role in nuclear import of the PIC, yet
it is not clear whether this feature is essential for the viral lifecycle.
NC protein
The nucleocapsid (NC) protein is a small basic protein, typically about 60-90 amino
acid residues long containing one or two copies of a Cys-His motif CX2CX4 HX4C
(CCHC). These sequences bind a single Zn2+ ion and fold around the ion in a
characteristic structure that is smaller and rather different from the better-known zinc-
finger structures, which have a role in binding of certain proteins to nucleic acids.
Indeed, NC has been shown to bind Zn2+ ions tightly (Bess et al., 1992) and in virions
it is closely associated with the viral RNA. Probably the entire RNA molecule is
coated with NC, in a stoichiometry of about one NC molecule per six nucleotides of
RNA. Deletions or major alterations of the CCHC result in the absence of viral RNA
in virions or alterations of the specificity of RNA packaging. Thus, this NC motif
probably interacts with the "packaging sequences" near the 5’end of retroviral
genomic RNAs when it is still part of the Gag precursor (Berkowitz et al., 1995). NC
also contains sequences that act as "assembly domains" (Wills and Craven, 1991),
which are required for assembly or budding of the virion. The assembly domains are
independent of the CCHC and are likely to coincide with the stretches of basic
residues.
In addition, NC promotes annealing of complementary RNA sequences (Prats et al.,
1988). For example, it stimulates reverse transcription by facilitating the annealing of
the primer tRNA to the primer-binding site. Under various conditions in vitro, NC can
stimulate the dimerization of RNAs, and association between tRNA and its
complementary sequence at the primer-binding site. Thus NC can help to promote
primer tRNA placement during virion assembly. Furthermore it is known, that NC
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can bind to double stranded nucleic acid, and thus it is probably retained on the viral
DNA after reverse transcription.
CA protein
The largest cleaved part of the Gag precursor is the CA protein with approximately
200-270 amino acid residues in size. The CA protein contains the only highly
conserved motif amongst gag proteins, the major homology region (MHR). The exact
structural function of CA in the mature viral particle has not been elucidated, but the
protein is believed to form a shell surrounding the ribonucleoprotein complex that
contains the genomic RNA, as originally suggested in the 1970s. The possibility that
other Gag proteins, perhaps in lower amounts than CA, also form part of the shell, has
not yet been ruled out. This shell is most appropriately referred to as the "capsid." The
capsid together with the components it encloses is then referred to as the "core." The
biological function of the capsid shell is not known. Other prototypic enveloped RNA
viruses, such as vesicular stomatitis virus (VSV, a rhabdovirus), hepatitis B virus (a
hepadnavirus) and influenza virus (a myxovirus), do not have such a separate shell
between the viral membrane and its associated matrix protein, and the RNA genome
and its associated nucleocapsid protein. In all of these viruses, the nucleocapsid
proteins are much larger than retroviral NC proteins, and thus perhaps carry out the
functions of CA and NC together. The proteolytic cleavage event that severs the
connection between the retroviral NC and CA, which is probably involved directly in
morphological maturation of the virus, may be necessary for a subsequent step in the
infectious cycle, for example, proper disassembly upon infection.
p6
In HIV-1 and other lentiviruses, a polypeptide of approximately 60 amino acids is
cleaved from the Gag protein downstream from NC in a region partially overlapping
the pro reading frame. This "p6" domain appears to have a role in release of virus in
the final steps of budding and incorporation of the Vpr proteins into the virion. Viral
particles from mutants with p6 deleted or altered remain tethered to the plasma
membrane (Gottlinger et al., 1991).
Introduction
17
Proteins derived from pol and pro
All infectious retroviruses carry three enzymes, reverse transcriptase (RT), integrase
(IN) and protease (PR) (Katz and Skalka, 1990). The RT protein also contains an
additional enzymatic activity, RNase H, which has been mapped to a separate,
contiguous portion of the polypeptide, and the conventional designation "RT" always
implies the protein with both reverse transcriptase and RNase H activities. The three
enzymes are translated together as a Gag-Pro-Pol precursor, which is processed late in
assembly to yield the mature forms of the enzymes. Since RT, IN, and PR are
essential for viral replication and have characteristics that distinguish them from
related cellular enzymes, they all have become targets for drug intervention in AIDS.
The reverse transcriptase, the most famous retroviral enzyme, is a relatively slow
DNA polymerase, incorporating under standard conditions only 1 to 100 nucleotides
per second, depending on the template. The enzyme also exhibits low fidelity and
therefore the misincorporation rate under physiological conditions is on the order of
10-4 errors per base pair incorporated. RTs do not exhibit a proof reading nuclease
activity and thus misincorporated bases are not removed as they are by host DNA
polymerases.
The RNase H, an endonuclease, was identified initially as an activity of RT that
degrades the viral RNA used as a template when permeabilized virions were
incubated under conditions where RT could function (Molling et al., 1971). The "H"
refers to the specificity of this enzyme for RNA/ DNA hybrids. Although always part
of the RT polypeptide, RNase H forms a distinct subdomain.
The actual integration of the viral DNA into a target is mediated in vivo by the viral
IN protein. Purified IN has the ability to recognize the ends of the newly synthesized
linear double-stranded viral DNA, to remove two nucleotides from the 3’end of each
strand, and to join this DNA ends to the genomic DNA. These activities are consonant
with the role IN has in viral replication in vivo.
Many viruses encode proteases, which typically have roles in processing of the
primary translation product and maturation of the viral particle. PR acts late in
assembly and budding, or perhaps immediately after budding, to cleave the domains
of Gag and Gag-Pol, causing profound morphological changes and converting the
particle into an infectious virus (Vogt, 1996). The dimerization is crucial for its
enzymatic activity, is likely to be involved in the regulation of proteolysis of Gag and
Pol proteins, and is therefore essential for proper virion formation.
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Proteins derived from env
Like all animal viruses that carry a lipid envelope, the surface of retroviral virions is
studded with glycoproteins (envelope or Env proteins), whose function is to mediate
the adsorption to and the penetration of host cells susceptible to infection. Therefore
the Env protein is the primary determinant of cellular tropism. All retroviruses contain
two different types of Env proteins, called SU (surface subunit; gp120) and TM
(transmembrane subunit; gp41) that are derived from a common precursor
polypeptide. Typically, both SU and TM proteins are glycosylated at multiple sites.
At the plasma membrane, the SU/ TM oligomers are incorporated into the budding
viral particle. The cytoplasmic "tail" distal to the membrane-spanning segment of TM
remains on the internal side of the viral membrane. It has been suggested that the
cytoplasmic tail of TM is in contact with the MA domain of the Gag protein in
virions, but the nature of this contact is unknown.
Retroviruses enter via membrane fusion into the target cell. HIV and SIV recognize
the same receptor, CD4, but for postbinding steps of membrane fusion and virus entry
various members of the chemokine receptor family, notably CCR5 and CXCR4, are
needed. Due to the specific receptor expression in host cells, HIV is mostly found in
helper T-cells, in dendritic cells, macrophages and in certain cells in the brain.
Rev
The regulatory protein Rev is a small, 13-kDa sequence-specific RNA binding
phosphoprotein. Rev mediates the export of unspliced and singly spliced viral RNAs
from the nucleus, thus permitting the expression of the Gag, Pol and Env gene
products. It binds to the Rev responsive element (RRE) present in the HIV-1 env
gene, and by interacting with Crm1, a member of the karyopherin family of
nucleocytoplasmic-transport factors, it acts to export the viral RNAs through the
nuclear pore (Cullen, 2003).
Tat
Tat is a unique RNA-binding transcriptional activator that binds to the hairpin
structure TAR (trans-activation response element), encoded in the LTR of nascent
RNA. Through this interaction, the protein promotes the assembly of transcriptionally
active complexes at the LTR (Berkhout et al., 1989) and increases the rates of
elongation by RNA polymerase II. Several studies have suggested direct roles for
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RNA polymerase II, general transcription factors, and various transcriptional
cofactors implicated in the Tat trans-activation mechanism (Kashanchi et al., 1994;
Sune and Garcia-Blanco, 1995).
Nef
Nef (negative factor, “historical name”) is a 24- to 35-kDa protein unique to the
primate lentiviruses HIV and SIV. Among the various HIV gene products implicated
in modulation of cell signaling, Nef appears to be the most potent. The nef gene,
expressed rapidly and abundantly following infection, is a major virulence factor both
in vitro and in vivo. Rhesus macaques infected with simian immunodeficiency virus
(SIV) rarely progress to disease if the viral nef gene is deleted. In humans, members
of a cohort of individuals infected with a nef-deleted form of HIV have remained
disease-free for many years (Miller et al., 1994). Nef leads, like Vpu, to loss of the
CD4 receptor, in this case directly from the cell surface and down-regulates MHC
class I levels, thereby inhibiting the cytotoxic T-lymphocyte-mediated lysis of HIV-1
infected cells. Finally, Nef may enhance virion assembly and release through
unknown mechanisms.
Vif and Vpu
The vif (viral infectivity factor) gene is needed for efficient replication of the virus in
primary CD4 cells. Vif enhances infectivity of virus produced in certain
nonpermissive cells. The recent identification and characterization of its target has
transformed the Vif protein, into an exceedingly hot topic. Vif's main function is now
identified as blocking the action of an antiviral protein, APOBEC3G, a cytidine
deaminase that attacks the viral DNA by degrading its genome before it can establish
a successful infection (Mangeat et al., 2003; Zhang et al., 2003).
The vpu gene product is found only in HIV-1 and very closely related viruses but not
in other primate or nonprimate lentiviruses. Vpu, a small integral membrane protein,
folds into two distinct structural domains with different biological activities: a
transmembrane (TM) helical domain involved in the budding of new virions from
infected cells, and a cytoplasmic domain encompassing two amphipathic helices,
which is implicated in CD4 degradation. CD4 is directly bound by Vpu and then
targeted for proteolysis in the cytosolic ubiquitin-proteasome pathway. However, the
molecular mechanism by which Vpu facilitates virion budding is not yet understood.
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Viral protein R (Vpr)
The accessory protein Vpr is a 14kDa protein incorporated in high levels into the viral
particle due to an interaction with the p6 domain of Gag. Therefore Vpr is a part of
the viral pre-integration complex (PIC). The function of Vpr is not understood in
detail, but numerous effects on the cell have been reported. Vpr causes a strong cell
cycle arrest in the G2 stage, which provides a replication advantage for the virus since
proviral transcription is highest during this stage. The protein was shown to act in
trans to increase the expression of viral proteins and to stimulate the expression of
heterologous genes driven by the LTR as well as other promoters (Cohen et al., 1990;
Forget et al., 1998; Goh et al., 1998). Vpr increases efficient replication of both HIV-
1 and HIV-2 in macrophages and, in addition to MA, is implicated in targeting of the
newly made viral DNA to the nucleus (Heinzinger et al., 1994). This targeting
function appears to be critical for the establishment of HIV infection in some
nondividing cells, which is a characteristic feature of lentiviruses. Additionally, upon
expression of Vpr in mammalian cells it is localized at the nuclear pore complex
(NPC), which could also play a functional role in the viral lifecycle (Le Rouzic et al.,
2002).
The possible involvement of Vpr with the nuclear import is actually a controversial
matter of debate. One theory for PIC nuclear translocation is based on the interaction
of different viral proteins with the cellular import machinery. The karyophilic nature
of the HIV PIC is attributed to three viral proteins MA, IN, and Vpr. While MA and
IN provide their nuclear localization signals (NLS) for the interaction with
karyopherin α, the cellular receptor for nuclear-targeted proteins, Vpr regulates this
process by increasing affinity of karyopherin α-NLS interaction. Without Vpr, viral
NLS-proteins and the HIV-1 PIC are weak or nonfunctional karyophiles (Popov et al.,
1998a). Others recently reported that Vpr expression in mammalian cells causes
herniations and large holes in the nuclear envelope, which may facilitate nuclear entry
of the viral PIC (de Noronha et al., 2001).
1.1.6 The retroviral life cycle
Retroviruses replicate through a complex life cycle and introduce a persistent
infection (Figure 3).
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In general the retroviral infection is divided into an early and a late phase. The early
phase starts with the attachment and specific receptor binding followed by a complex
mechanism of membrane fusion between the viral particle and the host cell
membrane. Fusion leads to “microinjection” of the HIV-1 capsid into the infected
host cell. Once inside, the capsid travels via microtubule tracks in an energy-
dependent fashion to the vicinity of the nuclear envelope (McDonald et al., 2002)
where the RNA genome is reverse transcribed into a double-stranded DNA and the
pre-integration complex (PIC) is assembled. Components of the PIC include the
double-stranded DNA version of the viral genome as well as the reverse transcriptase,
matrix, integrase, and Vpr proteins. Preliminary evidences point out that all these
steps take place inside the viral core and that only immediately before translocation
into the nucleus uncoating of the capsid happens.
Figure 3: The HIV life cycle
HIV associates with the CD4 and cognate coreceptor, initiating membrane fusion. The pre-integration
complex (PIC) facilitates conversion of viral RNA into cDNA and sheds several proteins while it
traverses the cytoplasm along microtubules towards the nucleus. The PIC, or at least the components
required for retroviral integration, somehow enters the nucleus to gain access to host chromosomal
DNA. After integration, genomic viral RNA is exported along with the immature viral particle
components, which assemble, and bud together out of the cytoplasm through lipid rafts (Sherman and
Greene, 2002).
After nuclear import, the viral DNA is inserted into chromosomal DNA with the aid
of virion integrase to form a stable provirus. With integration, the provirus achieves
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the status of a cellular gene, thus it is expressed and replicated by cellular enzymes in
concert with chromosomal DNA. All past-integration events are classified into the
late replicative cycle. Transcription of the provirus generates spliced and unspliced
mRNAs and full-length progeny RNA genomes that are then exported from the
nucleus with the assistance of the early transcript Rev. In the cytoplasm, viral mRNAs
are translated on cellular ribosomes. The translation products, together with progeny
RNA, are assembled at the cell periphery into viral particles that are released from the
cell by budding of the plasma membrane. Budding of viruses is followed by
proteolytic cleavage of virion polyproteins inside the new viral particle by the viral
protease as well as cellular proteases to generate mature and infectious progeny.
Introduction
23
1.2 Peptide Nucleic Acids (PNAs)
With respect to the epidemical state in the third world the urgent need of an efficient
therapy or treatment for HIV infected people seems to be obvious. Best current
projections suggest that an additional 45 million people will become infected with
HIV in low- and middle-income countries until 2010. Still no vaccine is available and
massive side effects and/or therapy resistances occur in the low percentage of patients
that can afford the highly active anti-retroviral therapy (HAART). For the more than
40 million HIV-infected people living in developing countries (25-28 million in sub-
saharan Africa), medication remains theory. Consequently, the quick development of
cheap anti-HIV drugs that are resistant to tropical climates is imperative (Piot et al.,
2001). Historically, vaccines have been the most efficient and cost effective means for
the control of infectious diseases, resulting in the eradication of smallpox and the
control of polio, yellow fever, and measles (Deming et al., 1997; Garenne, 1993; Hull
et al., 1997; Perraut et al., 2000).
Therefore a lot of research effort is spent into the development of an efficient vaccine
against HIV. The most studied attempts are recombinant protein trials or viral vector
systems, as Adenoviruses, Adeno-associated Viruses (AAV) or Measles viruses. In
parallel there are also studies on live attenuated simian immunodeficiency virus
(SIV), but, as retroviruses integrate into the host genome, this approach is
controversially discussed in the field. To date, after more that two decades of
research, only one HIV vaccine, a recombinant surface protein (gp120), went through
a trial process, which includes preclinical testing followed by three clinical phases,
with human volunteers. The objectives of this large scale vaccine study was to
prevent HIV infection in people who are at high risk for HIV infection but also to see
if the vaccine helps to slow the rate of disease progression in infected persons.
Unfortunately, the study did not show a statistically significant reduction of HIV
infection within the tested population, which was the primary endpoint of the trial.
This demonstrates that vaccine design is a very challenging problem of HIV research.
Additionally, therapy resistance to the highly active anti-retroviral therapy (HAART)
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is reported. Therefore it is still crucial to continue the research effort to develop new
anti-HIV therapies.
Hopeful tools for therapy purpose are peptide nucleic acids (PNAs) (Nielsen et al.,
1991) that were developed only recently. PNA are DNA mimics in which the sugar
phosphate backbone of natural nucleic acid has been replaced by a synthetic peptide
backbone (N-(2-aminoethyl) glycine) to which the nucleobases are linked through
methylene carbonyl linkers (Nielsen et al., 1994a) (Figure 4).
Figure 4: Structure comparison peptide, PNA and DNA
This simple and yet entirely new synthetic molecule has interesting and non-prototype
chemistry. By strict chemical means, PNA, is neither a peptide nor a nucleic acid,
since its backbone is an achiral uncharged polyamide. However, this atypical
backbone gives PNA most appreciated advantages over other DNA analogues like
phosphorothioates etc., as PNA oligonucleotides are not recognized by proteases or
nucleases and are therefore extremely stable in biological fluids (Demidov et al.,
1994). DNA recognizing proteins do not interact with the PNA oligomers of the same
nucleotide sequence, probably due to the lack of electrostatic interactions with the
backbone. Despite its achiral and neutral backbone, PNA are found to form very
stable duplexes with Watson-Crick complementary single stranded DNA and RNA
targets (Egholm et al., 1993). Duplexes between PNA and DNA or RNA are in
general thermally more stable than the corresponding DNA-DNA or DNA-RNA
duplexes mostly due to the lack of electrostatic repulsion (Jensen et al., 1997). All the
described qualities make PNAs potential candidates for new anti-HIV drugs.
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1.2.1 Chemical synthesis and properties of PNAs
The backbone of PNA carries 2-aminoethyl glycine linkages in place of the regular
phosphodiester backbone of DNA (Egholm et al., 1992), and the nucleotide bases are
connected to this backbone at the amino nitrogens through a methylene carbonyl
linker (Fig. 4). Being achiral, peptide nucleic acids can be synthesized without need
of any stereoselective pathway.
Since peptide nucleic acids and DNA have no functional groups in common except
for the nucleobases, the chemical stability of PNA differs significantly. Unlike DNA,
which depurinates on treatment with strong acids, peptide nucleic acids are fairly acid
stable. However, some chemical instability can derive from the free amino
functionality at the NH2 terminus, where a slow N-acyl transfer of the nucleobase
acetic acid or a cleavage of the amino-terminal PNA unit by ring closure can take
place, particularly under basic conditions. PNAs are charge-neutral compounds and
hence have poor water solubility compared to DNA. Neutral PNA molecules have a
tendency to aggregate to a degree that is dependent on the sequence of the oligomer.
PNA solubility is also related to the length of the oligomer and purine:pyrimidine
ratio.
PNAs hybridize to complementary DNA and RNA sequences in a sequence-
dependent manner, following the Watson-Crick hydrogen bonding scheme (Egholm
et al., 1993). The various duplexes of PNA feature a high thermal stability compared
to double stranded DNA (dsDNA) with decreasing values from pure PNA-PNA
duplex over PNA-RNA to PNA-DNA heteroduplexes. This high thermal stability of
the PNA hetreoduplexe compared to the corresponding DNA-DNA duplexes can be
attributed to a more favorable entropic contribution. It is important to mention that for
PNA-DNA and DNA-DNA duplexes, enthalpic changes ∆H are rather equal. It has
been suggested that the entropic contribution is possibly related to the ion release
associated with the formation of a hybrid duplex (Ratilainen et al., 1998). Moreover
PNA-DNA hybridization is severely affected by base mismatches and PNA can
maintain sequence discrimination up to the level of a single mismatch, which lowers
considerably the thermal stability of a heteroduplex.
Multi-stranded triplex structure containing both Watson-Crick and Hoogsteen base-
pairing is also possible and has an even higher thermal stability. But the binding of
homopyrimidine PNA to dsDNA usually does not result in a conventional triplex
complex (i.e. Hoogsteen binding in the major groove of the DNA-DNA helix), but
Introduction
26
rather in a triplex invasion complex in which one PNA binds to the homopurine DNA
stretch by ordinary Watson- Crick base pairing preferably in the antiparallel
orientation (the PNA N-terminal faces the 3’ end of the DNA strand), and another
PNA binds the PNA- DNA duplex by Hoogsteen binding (preferably in parallel to the
homopurine containing DNA strand). The strand invasion is favored by the presence
of internal A-rich regions in a duplex DNA and by moderately low ionic strength
(high salt stabilizes the DNA duplex). Because cytosines require protonation in the N3
position in order to make Hoogsteen interactions with N7 of guanine residues, this
particular structure involving CGC+ triplets shows pH dependence and is most stable
in the non physiological pH range of 5.0- 5.5. It has been found that the synthesis of
PNAs with changes of cytosine to pseudoisocytosine (ψiC or ‘J bases’) in the
Hoogsteen strand abolishes the pH dependence of the triplex without affecting the
stability of the interaction (Figure 5). Moreover, the stability of the invasive PNA2 -
dsDNA complex has been improved by chemical linking of the two strands of PNA
thus forming a so called bis-PNA (Egholm et al., 1995).
Figure 5: PNA2 binding to dsDNA by triplex strand invasion
Triplex invasion by homopyrimidine PNA oligomers. One PNA strand binds via Watson-Crick base
pairing (preferably in the antiparallel orientation), while the other binds via Hoogsteen base pairing
(preferably in the parallel orientation). It is usually advantageous to connect the two PNA strands
covalently via a flexible linker into a bis-PNA, and to substitute all cytosines in the Hoogsteen strand
with pseudoisocytosines which does not require low pH for N3 ‘protonation’.
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1.2.2 Antigene and antisense application of PNAs
Peptide nucleic acids are promising candidates for gene therapeutic drug design. In
principle, two general strategies can be adapted to design gene therapeutic drugs.
Oligonucleotides or their potential analogs are designed to recognize and hybridize to
complementary sequences in a particular gene whereby they should interfere with the
transcription of that particular gene (antigene strategy). Alternatively, nucleic acid
analogs can be designed to recognize and hybridize to complementary sequences in
mRNA and thereby inhibit its translation (antisense strategy). PNAs have been
described to have significant effects on replication, transcription, and translation
processes.
Inhibition of replication
An important effect of PNA is the possibility to inhibit the elongation of DNA primers
by DNA polymerase. Further, the inhibition of DNA replication should be possible if
the DNA duplex is subjected to strand invasion by PNA under physiological
conditions or if the DNA is single stranded during the replication process. Efficient
inhibition of extrachromosomal mitochondrial DNA, which is largely single-stranded
during replication, has been demonstrated. The PNA-mediated inhibition of the
replication of mutant human mitochondrial DNA is a novel and potential approach
toward the treatment of patients suffering from ailments related to the heteroplasmy
of mitochondrial DNA. Here, wild-type and mutated DNA are both present in the
same cell. Experiments have shown that PNA is capable of inhibiting the replication
of mutated DNA under physiological conditions without affecting the wild-type DNA
in mitochondria (Taylor et al., 1997). Others could show that a bis-PNA bound to the
template strand significantly reduces the DNA unwinding activity of the UL9
helicase, a herpes virus DNA helicase that is necessary for viral replication. This
inhibitory effect on the template strand can be explained by a model in which
translocation of the UL9 helicase in 3’ 5’ direction is impaired by the PNA binding
(Bastide et al., 1999).
Inhibition of transcription
Peptide nucleic acids are capable of arresting transcriptional processes by virtue of
their ability to form a stable triplex structure or strand displacement complex with
DNA. Such complexes can create a structural hindrance to block the stable function
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of RNA polymerase and thus are capable of working as antigene agents. Evidence
from in vitro studies supports the idea that such complexes are indeed capable of
affecting the process of transcription involving both prokaryotic and eukaryotic RNA
polymerases (Nielsen et al., 1994b; Praseuth et al., 1996). PNA targeted against
promoter regions can form a stable PNA-DNA complex that restricts the DNA access
of the corresponding polymerase. PNA strand displacement complexes, located far
downstream from the promoter, can also efficiently block polymerase progression and
transcription elongation and thereby produce truncated RNA transcripts. The PNA2/
DNA triplex arrests transcription in vitro and is capable of acting as an antigene
agent. But one of the major obstacles for PNAs as an antigene agent is that the strand
invasion or the formation of strand displacement complex is rather slow at
physiological salt concentrations. Amelioration can be achieved by introducing the
earlier described pH-independent pseudoisocytosines into the Hoogsteen strand of
bis-PNAs. It has been found that under physiological salt conditions, binding of PNA
to supercoiled plasmid DNA is faster compared to linear DNA (Bentin and Nielsen,
1996). This is relevant to the fact that the transcriptionally active chromosomal DNA
usually is negatively supercoiled, which can act as a better target for PNA binding in
vivo. In addition there is evidence that the binding of PNA to dsDNA is enhanced
when the DNA is being transcribed. This transcription-mediated PNA binding occurs
about threefold as efficiently when the PNA target is situated on the nontemplate
strand instead of the template strand. As transcription mediates template strand-
associated (PNA)2/ DNA complexes, which can arrest further elongation, the action of
RNA polymerase results in repression of its own activity (Larsen and Nielsen, 1996).
More recently, it has been shown that a 8mer PNA directed against angiotensinogen,
which is critical in the control of blood pressure, resulted in a significant decrease in
plasma angiotensin I and systolic blood pressure upon intraperitoneal (i.p.) injections
in hypertensive mice in vivo (McMahon et al., 2002).
Inhibition of translation
The basic mechanism of the antisense effects by oligodeoxynucleotides is considered
to be either a Ribonuclease H (RNase H) mediated cleavage of the RNA strand in
oligonucleotide-RNA heteroduplex or a steric blockage of the translation machinery.
Ideally, this renders the mRNA non-functional and therefore results in the inhibition
of synthesis of the specific protein. PNA/ RNA duplexes cannot act as substrates for
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RNase H, but the antisense effect of the peptide nucleic acid is based on the steric
blocking of either RNA processing or translation. Even though the PNA/ RNA duplex
is not a substrate for RNase H, the possibility that PNA can induce degradation of
targeted mRNA by alternative pathways cannot be excluded (Larsen et al., 1999).
Duplex-forming PNAs can effectively inhibit translation initiation in vitro when
targeted to the region spanning the AUG initiation codon. Triple helix-forming PNAs
can also hinder the translation process. Bis-PNA structures are capable of forming
internal triple helical constructs. In principle, if targeted against the coding region of
mRNA, PNA2/RNA triple helix-forming derivatives can also cause a stop in
translation, which can be easily verified by the detection of a truncated protein
(Knudsen and Nielsen, 1996). Thus, in general, duplex-forming PNAs can inhibit
translation in vitro if they are targeted towards the ribosome-binding site, whereas
triplex-forming PNAs are effective when targeted against polypurine targets
downstream of the translation initiation site. Moreover, it is observed that the target
position on the mRNA drastically influences the efficiency of antisense PNAs, so that
targets shifted just a few nucleotides can have varied effects on translation. The
design of a PNA therefore most likely has to be optimized for each target with respect
to length and, in the case of bis-PNAs, pyrimidine content (Doyle et al., 2001). Since
the discovery of PNA, a lot of studies in different fields report about antisense effects
of this new tool in vivo, what comprises in living cells as well as in animal models
(Liu et al., 2004; McMahon et al., 2001; Sazani et al., 2002). The reported ability of
PNA to affect gene expression by sequence-specific true antisense activity validates
their application as potential therapeutics.
1.2.3 Cellular uptake of PNA
The strong potential of PNA as antisense and antigene agent was soon established in
cell-free in vitro systems, but development ex vivo and in vivo was rather slow. The
reason has been the lack of efficient ways to introduce PNA into cells. The large
hydrophilic and uncharged molecule does not cross lipid membranes easily, which is
the major challenge to be overcome before PNA can be used as a therapeutic drug.
Brute techniques like microinjection, electroporation or detergent mediated cell
permeabilization were used to demonstrate effects of PNA treatment in living cells,
but all mentioned methods are not feasible for therapeutic purpose.
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Several proteins, such as HIV-1 Tat, Drosophila Antennapedia homeoprotein
(pAntp), and HSV-1 VP22 have been shown to traverse the cell membrane by a
process called protein transduction in an energy- and receptor- independent manner
(Elliott and O'Hare, 1997; Frankel and Pabo, 1988; Green and Loewenstein, 1988;
Joliot et al., 1991). Short peptides derived from the respective protein-transduction
domains (cell-penetrating peptides CCPs) can be internalized in most cell types and,
more importantly, allow the cellular delivery of conjugated biomolecules. Since this
discovery a lot of research effort has been spend to investigate the mechanism
allowing these proteins to overcome cell membranes. However, internalization of
CPPs and their cargo is not well understood yet and has recently been the subject of
controversies.
1.2.4 Therapy approach against HIV
Since HIV integrates into the host cell genome a highly sequence specific antigene
approach could be an alternative to existing antiviral treatments. Moreover, antisense
approaches against targets in the early viral live cycle have the advantage to neutralize
HIV before integration.
Until now, the main hurdle to overcome in PNA therapy approaches was the efficient
delivery of the drug in reasonable quantities without any noxious side effect. This
objective seems to be achievable with the above mentioned transport peptides. Klaus
Braun (DKFZ, Germany) has developed a complex transport shuttle for the PNA
delivery, that shows high efficiency at remarkably low doses (Braun et al., 2002). By
coupling the PNAs via a cleavable disulfide bond to a 16 amino-acid fragment in the
third helical domain of antennapedia protein (pAntp), efficient cellular transport was
ensured. The entry into the cytoplasm then results in the reductive splitting of the
disulfide bond and liberates the PNA from sterical binding hindrance due to the
transport peptide. Subsequently, for a therapy aimed to inhibit transcription, a next
barrier, the nuclear membrane, has to be overcome. Nuclear import mechanism of
macromolecules is energy-dependent and carrier-mediated. Karyophilic proteins bear
one or more nuclear targeting signal peptides called nuclear localization sequences
(NLS) (Kalderon et al., 1984), mostly short basic peptides, which ensure, the
translocation through the nuclear pore complex (NPC). Thus, the nuclear localization
sequence (NLS) of the simian virus 40 (SV40) large T antigen was covalently linked
to the N-terminus of the PNA construct, spaced by two lysine residues. Functional
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and efficient delivery of the PNA linked to the transport peptides could be shown
recently in a study targeting anti cancer compounds into the nucleus of a carcinoma
cell line (Braun et al., 2003).
According to these, at the time, preliminary results, we designed a set of 16- to 18-
mer PNAs directed against crucial sequences for an effective viral propagation in the
HIV genome. Targets in both, the early and late replicative cycle, were selected and
genomic databases were searched for highly conserved sequences in-between
different HIV clades.
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1.3    The actin cytoskeleton
1.3.1 Basic actin biochemistry
The actin nucleation machinery is very complex because a lot of different regulatory
proteins play an important role in the equilibrium between the monomeric and
polymerized state of actin. However the comprehension of this process is essential to
understand the interplay between the hosts actin cytoskeleton and pathogens like
several viruses or bacteria.
Actin is the most abundant protein in many eukaryotic cells. It exists in two forms:
monomers (G-actin or globular-actin) and filaments (F-actin or filamentous-actin).
The globular monomers form a double helical polymer, which is arranged head-to-tail
to give the filament a molecular polarity. The filaments are decorated with the motor
protein myosin and due to arrowhead pattern of the complex seen with electron
microscopy one end is called the barbed end and the other the pointed end. This
polarity is essential for the mechanism of actin assembly in living cells. Filament
growth is favored at the barbed end. This leads to a strong orientation of the actin
filaments outward with respect to the cell surface (Small et al., 1978). The rate-
limiting step of actin assembly is the instability of actin dimers and trimers, but once
started, filament growth is very rapid. Another determinant for growth is the diffusion
of monomers and the rate that subunits collide with the end, only 2% of such
collisions are in correct orientation for binding (Drenckhahn and Pollard, 1986). The
elongation rate is directly proportional to the monomer concentration in a given
solution. The critical concentration for filament growth is the ratio of rate constants
for dissociation and association (k-/k+), the dissociation equilibrium constant for
subunit binding at the end of a polymer. In living cells all actin (Mg-ATP actin)
polymerizes above the critical concentration of 0.1µM at the barbed end (where
growth is favored) and 0.7µM at the pointed end. The polymerization per se does not
require Mg-ATP, bound in a deep cleft it rather stabilizes the actin monomer (De La
Cruz et al., 2000). Hydrolysis of ATP by polymerized actin and thus the dissociation
of the γ-phosphate seems to be an indicator for the aging of filaments and triggers the
disassembly processes inside living cells. The ATP hydrolysis is not reversible
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(Carlier et al., 1988) and very fast with a half time of only ~2s (Blanchoin and
Pollard, 2002). In contrast phosphate dissociation is much slower (Carlier and
Pantaloni, 1986), and therefore new assembled filaments are marked with ADP-Pi-
actin as a relatively long-lived intermediate, which has the same properties as ATP-
actin. After the γ-phosphate is split of, ADP-actin subunits dissociate faster from the
barbed end than ATP-actin subunits, but both ATP- and ADP-actin dissociate slowly
at the pointed end (Pollard, 1986). Therefore in the steady state ATP-actin associates
at the barbed end and ADP-actin dissociates from the pointed end. These kinetc
constants are leading to very slow treadmilling of subunits from the barbed end to the
pointed end. This means, that actin filaments are continually built-in at one end,
where new actin-ATP complexes are added, and at the same time slowly falling apart
at the opposite end, where the actin-ADP form dissociates. The whole structure
slowly steps through the cell, in an ATP hydrolysis dependant mechanism, but never
gets any longer or shorter.
At the steady state, treadmilling in a pure actin solution under physiological
conditions is rather slow, whereas cells can advance or react quickly to external
stimuli. Therefore, the key point for this physiological behavior is a rich variety of
regulatory proteins. Cells feature more than 60 classes of actin binding proteins
(Pollard, 1999). These proteins are actin, ADF (actin-depolymerizing factor)/ cofilin
(Bamburg et al., 1999), capping protein (Cooper and Schafer, 2000), Arp2/3 complex
(Pollard and Beltzner, 2002), an activator of Arp2/3 complex (Weaver et al., 2003),
and profilin (Schluter et al., 1997). There are to many proteins participating in the
complex actin nucleation machinery to be mentioned here, but the cartoon below
(Figure 6) shows a selection of the essential players in the process. (Pollard and
Borisy, 2003).
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Figure 6: Actin treadmilling model for actin polymerization at the plasma membrane
(1) Extracellular signals activate receptors. (2) The membrane associated signal transduction pathways
produce active Rho-family GTPases and PIP2 that (3) activate WASp/Scar proteins. (4) WASp/Scar
proteins bring together Arp2/3 complex and actin monomer on the side of a preexisting filament to
form a branch. (5) Rapid growth at the barbed (+) end of the new branch (6) pushes the membrane
forward. (7) Capping protein terminates growth within a second or two. (8) Filaments age by
hydrolysis of ATP bound to each actin subunit (white subunits turn yellow) followed by dissociation of
the γ phosphate (subunits turn red). (9) ADF/cofilin promotes phosphate dissociation, severs ADP-actin
filaments and promotes dissociation of ADP-actin from filament ends. (10) Profilin catalyzes the
exchange of ADP for ATP (turning the subunits white), returning subunits to (11) the pool of ATP-
actin bound to profilin, ready to elongate barbed ends as they become available. (12) Rho-family
GTPases also activate PAK and LIM kinase, which phosphorylates ADF/cofilin. This tends to slow
down the turnover of the filaments. (Redrawn from a figure in (Pollard et al., 2000)).
1.3.2. Viral cytoplasmic locomotion
An important characteristic of eukaryotic cells is the requirement for cytoplasmic
transport. Cellular size and complexity is dependant on the effectiveness of its
transport mechanism. During mitosis and meiosis, genetic material is segregated into
daughter cells, whereas during interphase, endocytosed material or newly synthesized
mRNAs, proteins and lipids are transported to their final destinations (Fuchs and
Yang, 1999; Sheetz, 1999). Cytoplasmic transport and cell morphology depend on a
complex network of three cytosolic filaments: microtubules (MTs), intermediate
filaments (IFs) and microfilaments (actin). The cytoskeleton is highly dynamic and
reorganizes constantly as the cell responds to external stimuli, changes shape,
migrates over the extracellular matrix or divides. There is considerable synergy and
crosstalk between the different cytoskeleton filaments and the network is regulated by
a growing abundance of actin- and microtubule-binding proteins, kinases and
phosphatases, which are controlled by several signaling cascades (Gundersen and
Cook, 1999; Schmidt and Hall, 1998). Rather than allowing intracellular molecules to
diffuse freely in the cellular volume, the cytoplasm imposes a substantial barrier to
transport. Free diffusion of molecules larger than 500 kDa is restricted due to
molecular crowding effected by the presence of organelles, the cytoskeleton and high
protein concentrations in the cytoplasm. Diffusion coefficients measured for
cytoplasmic vesicles or microinjected beads are 500- 1000 times lower compared with
diffusion in aqueous solution (Luby-Phelps, 2000). For a 100bp DNA fragment,
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diffusion in the cytoplasm is approximately five times lower than diffusion in water,
and diffusion of a 250bp fragment and a 2000bp fragment is 17 and >100 times lower
(Lukacs et al., 2000). Thus, the very restricted diffusive mobility of beads, vesicles
and free DNA molecules in the cytoplasm suggests that movement of virions, subviral
particles and viral genome-protein complexes cannot rely on passive diffusion and
their cytoplasmic transport must therefore be an active process.
For many virus species penetration into the cell cytoplasm is insufficient to permit
replication. Specifically, all DNA viruses, except for pox viruses, as well as some
viral families that bear RNA genomes, including retroviruses and influenza viruses,
replicate in the nucleus. Only in the nucleoplasm these viruses gain access to the
cellular factors they require for amplification and transcription of their genome as
well as posttranscriptional processing of viral mRNA. Therefore, these viruses not
only have to cross the plasma membrane but must also traverse the cytoplasm and
then enter the cell nucleus. The entry of many different viruses, including adenovirus,
HIV and vaccinia, is actin dependent (Iyengar et al., 1998; Li et al., 1998; Locker et
al., 2000). Moreover a number of viruses appear to have evolved to use a common
retrograde transport mechanism that involves recruitment of cytoplasmic dynein, a
microtubule minus-end-directed motor, to move towards the microtubule organization
center (MTOC) (Kaelin et al., 2000; Sodeik et al., 1997; Suomalainen et al., 1999).
MTs are the cytoskeletal highways responsible for long distance transport of host as
well as viral cargo, whereas actin filaments are implicated in short distance motility.
In a recent study done by Tom Hope and colleagues (McDonald et al., 2002), it is
shown, that HIV infection is reduced twofold if cells are infected in the presence of
the MT-depolymerising drug nocodazole. Moreover, after microinjection of a dynein
function- blocking antibody, the relative transport towards the nucleus was
significantly reduced. Cytoplasmic dynein and kinesins, respectively, are so-called
motor proteins for transport either to the minus-ends of MTs at the MT-organizing
center (MTOC), or toward the plus-ends in the cell periphery. Yet a complete block of
the HIV pre-integration complex (PIC) at the plasma membrane could only be
achieved with drugs depolymerizing both the actin and the microtubule network. This
result is consistent with evidence that actin can be used to gain access to the
microtubule network. Generally, actin seems to play a role at several crucial steps
during the viral life cycle. Depolymerization of actin prior to viral infection impairs
CD4 and co-receptor clustering necessary for membrane fusion and entry (Iyengar et
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al., 1998). Subsequently, the cytoskeleton provides a cofactor or acts as a scaffold for
the appropriate localization and activation of the PIC and, ultimately, for efficient
infection (Bukrinskaya et al., 1998). Furthermore, the nucleocapsid (NC) domain of
the retroviral Gag protein directly binds actin (Liu et al., 1999) and it has been
reported that this interaction may be responsible for the incorporation of cytoplasmic
actin into retroviral particles (Wilk et al., 1999).
1.3.3 Routing of HIV particles from the MTOC to the nuclear envelope
It is now accepted that HIV travels along microtubule tracks through the cytoplasm
towards the nuclear envelope (McDonald et al., 2002). Yet little is known about how
viral particles move from the MTOC to nuclear pores as well or how nuclear actually
functions. As described earlier (chapter 1.1.5) there are several viral proteins present
in the PIC presumed to play a role in these procedures. A very good candidate to
fulfill both tasks seems to be Vpr. The karyophilic protein is present in the viral
particle and stays associated to the PIC during routing towards the nuclear envelope.
It has been shown that Vpr is shuttling between cytoplasm and nucleus, directly
interacts with the human nucleoporin hCG1 and therefore accumulates at the nuclear
membrane (Le Rouzic et al., 2002). Moreover, recent studies show that Vpr
expression in mammalian cells caused herniations and large holes in the nuclear
envelope (NE) (de Noronha et al., 2001). De Noronha et al. propose a model in which
Vpr enters the nucleus and disrupts the nuclear membrane from inside. Though it
seems that Vpr facilitates the entry of the viral DNA into the nucleus, yet the
underlying mechanism remains unclear. Interestingly, Vpr also alters the actin
cytoskeleton in yeast and mammalian cells (Gu et al., 1997; Matarrese et al., 2000;
Zhao et al., 1998). In CD4+ T lymphocytes, Vpr induces a significant increase of
polymerized F-actin and rearranges the filamentous structures (actin cables or stress
fibers). The pool of G-actin remains unchanged while an increase of the total actin
content was detected in Vpr-expressing cells (Matarrese et al., 2000).
These features suggest that Vpr may mediate the transition from the MTOC via the
actin cytoskeleton to the nucleoporins and thus facilitates nuclear import of the PIC.
To test this hypothesis, we investigated whether Vpr induced nuclear abnormalities
are linked to actin polymerization dynamics inside living cells and if a direct
interaction of the protein with actin can take place in vitro.
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The presumption of actin being involved in the transition of the PIC from the MTOC
to the nuclear envelope and maybe even in nuclear import can be supported by studies
describing a distinct pool of actin surrounding the nuclear envelope (NE). These
perinuclear actin filaments comprising a fine basket-like structure in the vicinity of
the NE-membrane have been reported for numerous cell types (Clubb and Locke,
1998; Riparbelli et al., 1993). However, little is know concerning the polymerization
dynamics likely to determine the functionality of this actin pool. Visualization with
specific drugs that label actin filament is often dependent on cell fixation whilst in
living cells, using green-fluorescent protein conjugates, the bright stress fibers drown
the fine structures of the perinuclear actin basket out. As we wanted to investigate a
dynamic phenomenon in the context of the viral infection we had to set-up a new
method to label actin inside living cells.
1.3.4 Visualization of dynamic actin inside living cells
Actin comprises 10 percent by weight of the total cellular proteins of muscle cells.
Even in nonmuscle cells, actin makes up 1 -5 percent of the whole protein content. A
typical cytosolic concentration of actin in nonmuscle cells is 0.5mM, however, the
local actin concentration can be tenfold higher in special structures like microvilli or
filopodia (tiny extensions protruding from the plasma membrane). This predominance
of actin compared with other cell proteins is a common feature of all cytoskeletal
proteins, because they form structures that must cover large spaces in cells.
Due to this high concentration of actin in eukaryotic cells, the visualization of
dynamic actin assembly is very challenging. Upon expression of actin linked to
fluorescent conjugates (such as the green fluorescent protein), fine and dynamic
structures are barely perceivable due to the high level of overall fluorescence. To
overcome this problem, we developed a new method, which only enlightens a distinct
pool of actin, taking advantage of a drug interfering with the actin polymerization.
Several natural toxins are known to perturb the equilibrium between actin monomers
and filamentous structures. The most commonly used are cytochalasin D, latrunculin
and phalloidin with different effects each. Cytochalasin D, a fungal alkaloid, binds to
the free barbed (+) end of actin filaments and thus blocks further addition of subunits.
Latrunculin, a toxin secreted by Red Sea sponges, binds monomeric actin and inhibits
it from adding to a filament end. Exposure to either toxin shifts the monomer-polymer
equilibrium in the direction of dissociation. When these drugs are added to living
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cells, the actin cytoskeleton disappears and cell movements like locomotion and
cytokinesis are inhibited. In contrast, phalloidin prevents actin filaments to
depolymerize. Isolated from Amanita phalloides (a mushroom), phalloidin binds at
the interface between monomer subunits in actin filaments and locks them irreversible
together. Even when actin is diluted below its critical concentration, phalloidin-
stabilized filaments will not depolymerize.
As cytochalasin D is binding to free barbed ends of actin filaments it seemed to be the
most appropriate drug to investigate dynamic actin polymerization. Additionally,
cytochalasin D appears to be somewhat membrane permeant and therefore can
potentially be used to manipulate actin polymerization in vivo. Applying a fluorescent
analogue of cytochalasin D in concentrations that inhibit polymerization gives a very
bright signal only minutes after adding to the cell medium. Yet, our intention for
using cytochalasin D was not to abolish polymerization but just to visualize the pool
of high turnover actin. Therefore we dropped the drug concentration to nanomolar
ranges, which are still giving a bright signal of actin polymerization hotspots but do
not impair the normal cellular metabolism. Hence using this approach we could
examine a new aspect of the actin cytoskeleton inside living cells.
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1.4    Objectives of the work
Nuclear import of the HIV pre-integration complex (PIC) an essential step in the early
viral lifecycle still remains elusive. Lentiviruses, such as HIV, have the feature to
translocate their genome in an active process into cell nuclei, even in non-dividing
cells. Amongst the proteins, put forward to be implicated in this process, the viral
protein R (Vpr) seemed to be an interesting candidate. Several studies showed that
Vpr induces aberrant nuclear morphologies and transient disorganization of the
cytoskeleton (Gu et al., 1997; Matarrese et al., 2000; Zhao et al., 1998). Therefore we
investigated the role of this particular protein in the nuclear import process to get
further insights into host pathogen interactions.
Furthermore we tested a novel antisense strategy based on PNAs to inhibit HIV
replication and viral spread. A broad spectrum of sequences in the HIV genome has
been targeted to study their potential relevance for antiviral effect. This approach is a
powerful new method to investigate the cell biology of the virus. Additionally, PNAs
could constitute new antiviral compounds, which can be further developed for
therapeutical approaches.
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2.1 PNA and peptide synthesis
PNA oligomers can be prepared following standard solid-phase synthesis protocols
for peptides (Merrifield, 1986; Merrifield, 1963). The scheme for protecting the N-(2-
aminoethyl) glycine backbone of PNA monomers (PE Bioscience, Germany) is based
on the N-(9-fluorenyl) methoxycarbonyl (Fmoc) chemistry while the exocyclic
amines of the nucleobases (A, C, G, T and ψ iC) are equipped with the
benzohydryloxycarbonyl (Bhoc) protecting groups. The solid phase synthesis of PNA,
as well as that of the peptides, was performed in a fully automated synthesizer Syro II
(MultiSyn Tech, Germany) on a TentaGel N resin (Rapp Polymere, Germany) using
the Fmoc strategy (Figure 7) (Merrifield, 1963).
Figure 7: Scheme of the Fmoc peptide synthesis
A : The Fmoc protecting group is base-labile, and removable with 20% piperidine in dimethyl
formamide (DMF). The following activation and coupling (acylation) must be maximally efficient to
ensure the quality of PNA products. B: Optimal conditions are highly dependent on the nature of the
activation reagent and the monomer-activated species. Thus we used HATU (O-(7-azabenzo-triazol-1-
yl)-1,1,3,3-tetramethyluronium hexafluoro-phosphate) as the coupling reagent. The activation is
accomplished by mixing monomer, HATU, and base solution containing DIPEA (diisopropylamine)
and lutidine. HATU activated carboxylic acids have demonstrated enhanced coupling efficiency in
peptide synthesis and are especially suited for hindered amino acid and other difficult couplings. C:
Monomers, that have been deblocked and activated but did not react with the resin in step A and B
must now be capped, to ensure the sequence accurateness of the ongoing synthesis.
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The postsynthetic modification of PNA uses coupling of a desired group to an
introduced lysine or cysteine residue in the PNA. Amino acids can be coupled during
solid-phase synthesis or compounds containing a carboxylic acid group can be
attached to the exposed amino-terminal amine group to modify PNA oligomers.
Therefore at the N-terminus of the PNA we introduced a spacer of 2 lysines (KK), to
prevent spatial binding hindrance of the following nuclear localization sequence
(NLS), derived from the simian virus 40T antigen (PKKKRKV) (attached only to
PNAs designed for anti gene therapy) and/or one cysteine to enable linkage with a
transport peptide. To promote cellular import of the PNAs, the 16 amino acid residues
(RQIKIWFQNRRMKWKK) derived from the third helix of the antennapedia
homodomain (pAntp(43–58)) of Drosophila were linked via a cleavable disulfide
bond to the PNA construct (Derossi et al., 1996) (Figure 8).
Figure 8: Scheme of PNA transport construct
PNAs designed for anti gene therapy were synthesized from the C-terminus and directly linked to a
double lysine spacer (KK) as well as the [SV40 T] NLS sequence. The synthesis was finished with a
single Cystein at the N-terminus for further coupling with the cell transport peptide pAntp. PNAs
meant to inhibit translation or the early events in the HIV live cycle had only the additional Cystein at
their N-terminus. After purification and characterization the PNA-NLS or -Cys hybrid molecules were
linked, under oxidizing conditions, over a cleavable disulfide bond to the pAntp peptide.
Postsynthesis procedures involve cleaving PNA oligomers from the solid support by
treatment with trifluoroacetic acid. Then PNA is precipitated by ice-cold diethyl ether
and dissolved in 0.1% trifluoroacetic acid solution. All synthesis products were
purified by preparative HPLC (Shimadzu LC-8A, Japan) on a YMC ODS-A 7A S-7
µm reverse phase column (20 x 250 mm), using 0.1% trifluoroacetic acid in water
(eluent A) and 60% acetonitrile in water (eluent B). Peptides were eluted with a
successive linear gradient, increasing from 25% to 60% B-eluent in 49 min at a flow
rate of 10 ml/min. The fractions corresponding to the purified conjugate were
lyophilized. Sequences of single modules as well as the complete constructs were
characterized with analytical HPLC (Shimadzu LC-10, Japan), using a YMC-Pack
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Pro C18 (150 x  4.6-mm inner diameter) S-5-µm, 120A column with 0.1%
trifluoracetic acid in water (eluent A) and 20% acetonitrile in water (eluent B). The
analytical gradient ranged from 5% (eluent B) to 80% (eluent B) in 35 min. Finally
the mass of the constructs was verified by matrix-assisted laser desorption ionization
time-of-flight (MALDI-TOF) mass spectrometry (Finnigan, Vision 2000). The
Cysteines of the pAntp peptide and the PNA or PNA-NLS construct were oxidized at
the range of 2 mg/ml in a 20% dimethyl sulfoxide (DMSO) water solution. Five hours
later, the reaction was completed. The excess DMSO was washed out with water by
several freeze-drying steps (Table 2).
Mol. Weight
in [g/mol]
Yield of PNA synthesis after pAntp
coupling and purification
pAntp(43–58) 2350,92 in [mg] in [µmol]
PNA +/- NLS PNA + pAntp
PNA I Cys 4811,4 7160,3 1,0 0,140
PNA I NLS 5933,2 8282,1 1,81 0,219
PNA II Cys (21mer) 5741,4 8090,3 2,18 0,269
PNA II NLS 6045,3 8394,2 0,6 0,071
PNA III Cys (21mer) 5879,4 8228,3 0,64 0,078
PNA III NLS 6183,2 8532,1 0,34 0,040
PNA III NLS (21mer) 7001,0 9349,9 0,93 0,099
PNA IVa Cys 5039,7 7388,6 0,99 0,134
PNA IVb Cys 4831,4 7180,3 1,86 0,259
PNA Va NLS (21mer) 6910,0 9258,9 2,24 0,242
PNA Vb NLS 6025,2 8374,1 2,09 0,250
PNA Vc NLS 6095,2 8444,1 1,11 0,131
PNA VI Cys 4781,4 7130,3 1,69 0,237
PNA VIIIa NLS 6022,2 8371,1 1,53 0,183
PNA VIIIb NLS 6077,2 8426,1 2,22 0,263
Random Cys 4924,5 7273,4 1,65 0,227
Random NLS 6046,1 8395,1 0,67 0,080
Table 2: Molecular Weight and yield of the completed PNA synthesis
Table highlights molecular weights (in g/mol) of all synthesized PNA constructs before and after
coupling to pAntp. All PNAs were synthesized as 18mers, if not stated differently. On the right part of
the table the yield in [mg] and [µmol] of the final synthesis product is shown.
After synthesis, PNAs were stored lyophilized at 4˚C and dissolved in phosphate
buffered saline (PBS) prior to use. The aliquot in use was kept at 4˚C and when
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necessary further diluted in PBS or cell culture medium (DMEM); the stock solution
was stored at 20˚C.
2.2 Experimental systems to test viral production in early and late life cycle
Virus and cell lines
The virus used in this study was derived from the pLAI3 infectious molecular clone
(Charneau et al., 1992), which carries the complete sequence of the HIV-1 LAI isolate
(Wain-Hobson et al., 1991).
The indicator cells used are HeLa-CD4+ cells that carry the lacZ gene under the
control of the HIV-1 LTR (Charneau et al., 1994). Additionally the HIV-1 coreceptor
CCR5 is expressed on the surface of the HeLa-CD4+ cells, therefore cells can be
infected by T cell-adapted HIV-1 strains (including primary isolates), that need this
coreceptor for infection, (Verrier et al., 1997). HeLa P4-CD4+/CCR5 (HP4) cells
were grown in Dulbecco's Modified Eagle Medium (DMEM (GIBCO)) supplemented
with 10% fetal calf serum and 500 µg/ml of G418 (GIBCO).
Persistently infected cells were obtained by infection of HP4 cells with the HIV-1
LAI isolate and several passages in culture medium under G418 selection pressure.
Conservation of viral infection was regularly tested with a p24 ELISA assay.
Virus infections and assay readout protocols
HP4 cells plated in 96-well plates were infected for each experiment in triplicate with
equivalent amounts of pLAI3 molecular clone (0.5ng of p24 viral antigen per well), in
the presence of 20 µg/ml of DEAE-dextran.
The inhibition by PNAs targeting early life cycle stages was revealed by the activity
of the reporter gene lacZ. The ß-galactosidase activity was measured 48 hours after
infection using a chemiluminescent ß-gal reporter gene assay (Roche) according to
the instructions of the manufacturer. HP4 cells (~2x104 cells/well) were treated at
stated concentrations with PNAs in 96 microwell plates and subsequently infected
with virus as described above. After 48 hours incubation time, cells were washed and
lysed for five minutes in a buffer containing 0.5% Triton X-100 and a protease
inhibitor cocktail. In a photometric assay the enzymatic hydrolysis of the ß-
galactisidase substrate o-nitrophenyl-ß-D galactopyranoside (ONPG) is measured.
ONPG is colorless but on hydrolysis resulting in o-nitrophenol that is yellow in
alkaline solution (pH 7.5). The substrate is added in excess to the lysates. After 15
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min the reaction is stopped with a concentrated solution of Na2CO3, which shifts the
pH to ~11, inactivates ß-galactisidase, and maximizes the absorbance of o-nitophenol
at 420 nm. The optical density of the solution at 420 nm is read on a Wallac (Victor2)
spectrophotometer and calibrated against the absorbance of a standard curve.
PNA inhibition of late replicative steps was tested on persistently infected cells
(described before). Cells were treated at stated concentrations with the different PNAs
and the supernatants were tested for viral load using an HIV-1 core profile enzyme-
linked immunosorbent assay (ELISA), quantifying the amount of p24 capsid protein
(Kit; PerkinElmer Life Science). Briefly, an aliquot of cell culture supernatant was
diluted 1/10 in sample diluent and lysed with 0.5% Triton X-100. Then dependent on
expected viral load, further dilution (in general 1/1000 or 1/10000) were prepared.
200µl of each sample were tested in duplicate by adding it directly to a monoclonal
antibody-coated microplate. The captured antigen is complexed with biotinylated
polyclonal antibody to HIV-1 p24, following by a streptavidin-HRP (horseradish
peroxidase) conjugate. The resulting complex is detected by incubation with ortho-
phenylenediamine-HCl (OPD), which produces a yellow color, whose intensity is
directly proportional to the amount of HIV-1 p24 captured. The absorbance of each
microplate well is determined using a microplate reader (Bio-Rad) at a wavelength of
492 nm with the reference at 620 nm and calibrated against the absorbance of an
HIV-1 p24 antigen standard or standard curve.
2.3 Cell culture
Cell lines
HeLa (ATCC), NIH-3T3 mouse fibroblasts, baby hamster kidney cells (BHK1;
expressing functional, green fluorescent protein (GFP) conjugated nucleoporin
POM121) and HeLa cells expressing the LaminA protein fused to the red fluorescent
protein (DsRed), were cultured in complete DMEM (DMEM Glutamax (Invitrogen),
10% FCS, 100U/ml streptomycin, 100µg/ml penicillin) at 37°C in an atmosphere of
95% air / 5% CO2 and subcultured every 4-5 days. To subculture, cells were washed
twice with PBS, without Ca2+ and Mg2+ (Invitrogen), and then detached from their
plastic support with 1x Trypsin-EDTA (0.25% Trypsin; 1mM EDTA, Invitrogen) for
5 min at 37˚C. To store the cells in liquid nitrogen, we froze them progressively
(about 1°C per hour) in culture medium supplemented with 10mM HEPES
(Invitrogen) and 10% DMSO (Sigma) at pH 7.4.
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Transient plasmid expression
The expression of Vpr-GFP was achieved by transient transfection of the plasmid
pVprGFP (derieved from pEGFP-N1 (Clontech Inc.); containing Vpr between Pst I-
Bam HI) with Fugene6 (Boehringer-Mannheim) according to manufacturer protocol.
The nuclear pore labeling in HeLa cells was achieved by transfection with a plasmid
(pcPOM121-GFP) containing POM121-GFP (pcDNA1Neo (cut by Xho I and Xba I))
(Imreh et al., 1998; Soderqvist et al., 1997) (kind gift of E. Hallberg, University
College, Huddinge).
Synchronization
Populations of mitotic cells were either produced by a single overnight (~18 hours)
thymidine block (2.5mM, Sigma) (Fang et al., 1998) or by an overnight incubation
(17h) with Aphidicolin (an inhibitor of DNA replication) (0.5µg/ml, Sigma).
After the blocking, cells were washed with PBS and grown in fresh medium without
thymidine or Aphidicolin for ~8 hours prior to use.
2.4 Molecular biology techniques
Agarose gel electrophoresis
This is a method to separate DNA strands according to size, allowing to determine the
size of the separated strands by comparison to strands of known length (marker). Due
to the negative charges of its phosphate backbone, the DNA moves toward the
positive electrode in an electric field. An optimal separation, between small and big
fragments, is achieved by using an appropriate agarose concentration (between 0.8%
and 1.5%). The agarose is dissolved in TAE buffer (2M Tris, 250mM Na-Acetate,
50mM EDTA; PH 7.8) by boiling. After cooling down to ~50˚C, ethydium bromide
(intercalating agent to stain nucleic acids; upon exposure to UV light it will fluoresce
a red-orange color) was added (0.5µg/ml,) and the solution is filled into a gel rack.
DNA was diluted in 4x sample buffer (50mM EDTA, 50% v/v Glycerin, small
amount of bromophenol blue to stain) and injected into gel slots. For separation, a
current of 60V-100V was applied in gel racks filled with TAE buffer.
When DNA was prepared for further use (i.e. in ligation), the band was cut out of the
gel and purified using a Qiagen Gel-Purification kit protocol. The purified DNA was
then dissolved in TE-buffer (10mM Tris, 1mM EDTA; pH 8).
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Molecular cloning
For cloning purpose, target DNA was cut with restriction enzymes (or restriction
endonucleases). These are enzymes that cut double stranded DNA in a sequence
specific manner without damaging the nuclear bases. The chemical bonds cleaved by
restriction enzymes can be reformed by other enzymes known as DNA ligases.
Therefore restriction fragments carved from different chromosomes or genes can be
spliced together. The DNA digestion was performed according to the manufacturer’s
manual in the appropriate buffer and at the indicated temperature. The amount of
enzyme used per digestion was adjusted to the amount of DNA to be cut in the
preparation; in general 0.5 units/µl per preparation (1 unit of any enzyme is the
amount capable to cut completely within one hour 1µg DNA under optimal salt and
temperature conditions).
Ligation of DNA fragments
The in vitro combination of two DNA fragments was achieved with a DNA-ligase, an
enzyme able to ligate two strands, by the formation of covalent phosphodiester bonds.
For the reaction, DNA-vector and insert were added in equimolar concentration (0,5-
1µg) mixed in a total volume of 20µl with 1µl T4-DNA-Ligase and 2µl 2x Ligase-
buffer and incubated for at least 4 hours at 16˚C.
Polymerase Chain Reaction (PCR)
The Polymerase Chain Reaction (PCR) provides an extremely sensitive means of
amplifying small quantities of DNA in vitro. The technique was made possible by the
discovery of Taq polymerase, the DNA polymerase purified from the bacterium
Thermus aquaticus living in hot springs. This DNA polymerase is stable at the high
temperatures needed to resist several cycles of strand separation at high temperatures.
PCR is based on the DNA polymerization reaction. A sense/antisense primer-pair,
framing the region of interest, and dNTPs are added along with a DNA template and
the DNA polymerase. The original template is melted (at 94˚C), the primers are
annealing (at ~45-55˚C) and the polymerase produces two new strands (at 72˚C),
doubling the amount of DNA present. This provides two new templates for the next
cycle. The DNA is again melted, primers anneal, and the Taq polymerase generates 4
new strands which results in an exponential amplification of the template.
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Reactions were performed in a total volume of 100µl with a DNA content of 10-20ng
(purified Plasmid DNA), 1µl Taq Polymerase, 10µl 10x buffer (purchased with the
enzyme), 2µl of a 10mM dNTP stock solution and ~2-3µl of each primer of a 10µM
stock solution.
The annealing temperature was calculated according to: [4x(GC) + 2x(AT)]
x18/length of primer. To gain the final annealing temperature we subtracted another
5˚C from the calculated result. Anneling time was calculated knowing that the Taq
Polymerase is adding ~ 1000 nucleotides/ minute.
2.5 Microscopy
Immunostaining
Cells or isolated nuclei were fixed for 20 min with 4% paraformaldehyde in
cytoskeleton buffer (10mM MES, 3mM MgCl2, 138mM KCl, 2mM EGTA and
0.32M sucrose, pH 6.1), then permeabilized for 5min with 0.5% Triton X-100 in PBS
and incubated successively with appropriate fluorescent markers as indicated:
phalloidin Alexa-488 (staining actin filaments (F-actin); Molecular Probes) (1/200, 20
min); Hoechst 33342 (Sigma-Aldrich) (0.001mg/ml, 10 min,); monoclonal antibody
mAb414 (staining the NPC; Babco, USA) (1/5000 in PBS supplemented with 10%
horse serum, overnight at 4˚C), followed by secondary, anti mouse CY3 conjugated,
antibody (Jackson ImmunoResearch Laboratories, Inc.) (1/200 in PBS supplemented
with 10% horse serum, one hour at RT).
Treatment of cells with “cytoskeleton drugs”
HeLa cells expressing POM121-GFP were incubated for 30 minutes with either 1µM
Cytochalasin D (CD) (Sigma), 1µM LatrunculinA (LatA) (Molecular Probes) or
200nM Jasplakinolide (Jaspl) (Molecular Probes) at 37°C (additionally DMSO
vehicle control according to stock solution of all drugs). Following the drug
treatment, cells were fixed and co-stained with Hoechst 33342 as described above. In
two independent experiments, at least 200 nuclei were counted and analyzed for each
experimental setup (samples and controls respectively).
For the live cell experiments the CD-BODIPY loading solutions were freshly
prepared by serial dilution of a 1mM stock solution (in DMSO) into experimental
medium to give the stated final concentrations. Facile staining of cells was achieved
by continuous incubation of cells in this solution for twenty minutes. With very low
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concentrations, cells could be maintained for several hours before any deleterious
effects were observed. Co-visualization using bright-field transmission observation
was used routinely to ensure that observed cells were flat, adherent and healthy. The
cell permanent, minor groove binding, AT selective, fluorescent DNA stain
HOECHST 33342 (Sigma) was added to the experimental medium where stated (final
concentration 1µg/ml) in order to reveal chromatin distribution inside living cells.
Microinjection.
HeLa cells expressing POM121-GFP were microinjected with either 10µM actin-
Alexa568, or Dextran-Rhodamine 70kDa (2.5mg/ml) using a Femtojet/Injectman
micromanipulator (Eppendorf, Hamburg, Germany).
Live cell image acquisition
For live cell imaging, cells grown on MatTek’s glass bottom microwell dishes
(MatTek Corporation, 35mm) were exchanged into OptiMEM medium (Gibco BRL).
On the microscope stage, cells were maintained at 37°C with a Zeiss “Tempcontrol
37-2 digital” heating chamber.
"High-resolution" fluorescent imaging in living cells was performed using two
different types of microscope customized to achieve maximal spatial resolution; either
a wide-field fluorescence imaging or a high-speed spinning disk confocal system. The
wide-field system was built around an upright microscope (DM-RXA, Leica,
Germany) equipped with a Nomarski filter. For high-resolution imaging, a 100x oil
immersion, infinity corrected objective (PL APO, Leica) was used. The light-
gathering ability of a microscope objective is quantitatively expressed in terms of the
numerical aperture (n.a.), which is a measure of the number of highly diffracted
image-forming light rays captured by the objective. Higher values of numerical
aperture allow increasingly oblique rays to enter the objective front lens, producing a
more highly resolved image. The n.a. of the objective we used was 1.4, and we
calculated the maximum spot resolution and focal depth to be ~0.2µm and ~0.25µm
respectively (Taylor and Salmon, 1989). Fluorescent emission was detected directly
using a 12-bit digital integrating CCD camera (C4742-95, Hamamatsu, Japan). No
signal binning was used in order to maintain maximum x-y spatial resolution. Image
acquisition control and processing used OpenLab software (Improvision, UK). The
high-speed spinning disk confocal system (UltraView RS- Perkin-Elmer, USA)
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equipped for dual wavelength acquisition, and built around a Zeiss (Germany)
inverted 200M microscope. Cells were visualized using a Hamamatsu ERII firewire
detector and a 100x NeoFluor 1.3 n.a. objective yielding pixel resolution ~208nm
(2x2 binning), and fast axial sampling used a piezo-objective drive stepping at
200nm.
Time-lapse acquisitions with cells only expressing GFP were achieved using a
standard Zeiss Axiovert 200M microscope equipped with a Plan-Fluar 100x
objective, n.a. 1.45. The microscope is controlled by Till Vision (Till photonics,
Germany) designed for fast live cells imaging and equipped with a xenon lamp,
polychromator for precise wavelength selection and a Till Photonic Imago QE CCD
camera.
Images from some experiments on fixed cells were acquired using an upright Zeiss
Axioplan2 microscope, with the Zeiss Axiovision 4.1 software and an integrated
ApoTome applet. (63x PlanApochromat n.a. 1.3, equipped with an Axiocam MRm
b&w camera).
Deconvolution and reconstruction
All axial image datasets were identically treated. First using geometric light
reconstruction (deconvolution) based on a calculated point-spread-function (PSF)
estimate. Deconvolution is necessary for the recovery of an object from an image that
is degraded by blurring and noise. In microscopy, the blurring is largely due to
diffraction limited imaging by the instrument and the noise is usually photon noise.
The PSF (the image of a single point object) can be obtained by recording the image
of a sufficiently small object like a fluorescent bead. Most lenses are not perfect
optical systems. As a result, visual stimuli that pass through the lens will undergo a
certain degree of degradation, meaning the lens will introduce a small amount of blur.
So if the relative intensity of this point of light were plotted as a function of distance,
one would obtain a Gaussian distribution. This curve is called the "point spread
function" (PSF) and this function is essential for the deconvolution algorithm.
Following the calculation of the PSF, the “maximum likelihood estimate” iterative
algorithm is applied both algorithms are available through Huygens software
(Scientific Volume Imaging, Netherlands), and tuned using the commercially available
plug-in “Nipkow-disk”. Second, the deconvolved results were then 3D reconstructed
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and partly analyzed using the “Co-loc” option of Imaris (Bitplane, Switzerland). All
two-color, three-dimensional rendering and reconstruction used the same software.
CD-BODIPY in vitro measurements
Purified, native and fluorescent (FITC) conjugated rabbit skeletal muscle actin
(Cytoskeleton, Denver, U.S.A.) in 2µl stock aliquots (10mg/ml; 222µM; containing
2mM Tris-HCl, 0.2mM CaCl2, 0.2mM ATP, 0.5mM DTT, 2% sucrose, and 0.005%
NaN3 (pH8.0)) was prepared at working dilutions (0.5-0.75 mg/ml; 11-17µM) by
addition of low salt buffer (5mM Tris-HCl, 0.2mM Na-ATP, 0.5mM DTT, 0.2mM
CaCl2, pH8.0). For each experiment, a single fresh actin stock was used. Stock and
aliquots were maintained at 4°C. Drugs were added, yielding the final concentrations
stated. Samples were vigorously mixed by pipette, vortexed and then left on ice for 1
hour before being clarified (100 000xg, 4°C, 30min). Supernatants were added to 5x
concentrated high salt polymerization buffer giving final concentrations of 100mM
KCl and 10mM Mg-ATP in the low salt buffer. After mixing, a 5 µl droplet was
sealed under a glass cover slip on a microscope slide and incubated at 37°C for at
least 3 hours to allow actin to fully polymerize to a steady state (Carlier et al., 1986)
before semi-quantitative observation using fluorescence microscopy. Each experiment
(triplicate samples) was performed at least twice yielding comparable results.
2.6 Biochemistry
SDS-PAGE
Polyacrylamide gel electrophoresis (PAGE) is used to separate heterogenous protein
mixtures (Laemmli, 1970). The polyacrylamide gel matrix is formed by the co-
polymerization of two monomers: acrylamide and bis-acrylamide. The acrylamide
polymerizes into long chains, which are crosslinked at intervals by the bis-acrylamide,
forming polyacrylamide. The porosity of the matrix can be altered by changing the
percentage of acrylamide in the mixture; higher percentage of acrylamide gives better
separation of small proteins. The gel is composed of two components one low
concentrated stacking gel, to concentrate the sample, and a separating gel on the
bottom with the required matrix pore size. In order to most accurately separate
proteins according to their sizes, the proteins must be denatured. The anionic
detergent sodium dodecyl sulfate (SDS) is used as the denaturing agent in gel and
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sample buffer. SDS is an amphipathic molecule with a long hydrophobic tail and a
small negatively charged head group. The hydrophobic portion of the molecule coats
the protein, disrupting the secondary, tertiary, and quaternary structures. Another
consequence of treatment with SDS is that the proteins are artificially coated with
negative charges. Therefore, in an electric field, they migrate toward the positive pole.
Since the proteins are denatured and the negative charge on the proteins is
exceedingly large, the primary factor determining the rate of migration of the protein
through the matrix is the size of the protein.
Samples were resuspended in sample buffer (250mM Tris, pH 6.8, 2% SDS, 20%
glycerol, 0.08% bromphenol blue, 2mM EDTA and 20mM dithiothreitol (DDT)) and
boiled for 5 minutes at 100˚C. The gels were run on a Biorad gel electrophoresis
apparatus in buffer containing 25mM Tris, 0,2M glycine and 1% SDS, pH 8.5 at
~100V- 150V. After the run, the gel was either further processed for immunoblotting
or stained with coomassie blue stain (0.25% coomassie blue R-250 (w/v) in 45%
Ethanol and 10% acetic acid) for 20 minutes and destained with a solution containing
45% ethanol and 7.5% acetic acid to reveal proteins directly on the gel.
Immunoblot (Western Blot)
Proteins separated in an SDS-PAGE can be transferred to a solid membrane for
western blot analysis. For this procedure, an electric voltage is applied to the gel, so
that the separated proteins migrate through the gel onto a nitrocellulose membrane
(Schleicher & Schull Optitran BA-S 83) in the same pattern as they were separated on
the SDS-PAGE. After the transfer in a wet apparatus (Biorad) in buffer containing
48mM Tris, 39mM glycine and 20% v/v ethanol, the transfer efficiency was checked
by coloring of the membrane with Ponceau S Solution (Sigma; 0,1% w/v ponceau S
and 5% acetic acid diluted in 1/5 in water). Ponceau S is staining all proteins on the
nitrocellulose membrane with a detection limit of 250ng and has the advantage to be
easily removable by washing with destilled water. Subsequently the membrane was
blocked (in order to prevent non-specific protein interactions between the membrane
and the antibody) with 5% (w/v) milk in PBS for 15 minutes at RT (or overnight at
4˚C) and incubated with a specific primary antibody which recognizes only the
protein of interest (diluted at indicated concentration in 5% milk/PBS) overnight at
4˚C (or 1 hour at RT). The membrane was then extensively washed with PBS (3 x 10
min) and incubated with a secondary peroxidase-conjugated antibody, specific for the
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species in which the primary antibody was raised, (also diluted at indicated
concentration in 5% milk/PBS) for 1 hour at room temperature. Again the membrane
was washed with PBS (3 x 10 min), developed according to manufacturer’s
instructions using a reaction Kit (Chemiluminescence HRP substrate; Pierce) and
exposed to an X-ray film (hyperfilm ECL 18x24, Amersham) for the appropriate time
period (30 seconds to several minutes, depending on the intensity of the band).
2.7 Actin polymerization assays
Bead coating and motility assay
Carboxylated polystyrene beads (Polysciences), 0.5µm, were first washed in storage
buffer (0.1M NaH2PO4, 0.1M Na2HPO4, pH 7,4) and then incubated in protein
solution either containing 1mg/ml chemically synthesized Vpr protein (in H2O, 5mM
DTT) or, as controls, 1.8mg/ml ActA or 2mg/ml ovalbumin. In all cases, conditions
were such that the amount of protein was saturating. For example, 2µl of 0.5µm beads
(2.5% solids) were added to 10µl of protein solution. Beads were incubated in protein
solution for 1 hour at 4˚C on a rotating wheel then pelleted and washed in buffer B
(20mM Tris-HCl, pH 7.8, 100mM KCl, 1mM MgCl2, 0.2mM ATP, 0.1% Tween 20,
and 0.2% BSA) and resuspended in 30µl of buffer B. Protein-coated beads were
stored on ice or at 4°C and were used within 1 week.
For visualizing bead motility, coated beads (0.5µl) were added to Xenopus laevis egg
cytoplasmic extract (10µl) supplemented with tetramethylrhodamine-labeled actin
(0.5µl of 60µM rho-actin (Cytoskeleton, USA)), creatinine phosphate (0.65µl of
500mM stock) and ATP Mg2+ (1µl of 10mM stock). The assay mix was allowed to
incubate on ice for 1 hour. Then, a 2µl sample was removed and squashed between a
microscope slide and a 22-mm-square glass coverslip, sealed with
vaseline:lanolin:paraffin (at 1:1:1), and incubated at RT for 30 minutes in the dark
before observing on the microscope. All observations were performed on the wide-
field fluorescence imaging system built around an upright microscope (DM-RXA,
Leica, Germany). Image acquisition control and processing used OpenLab software
(Improvision, UK).
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Actin polymerization
Actin, isolated from rabbit skeletal-muscle (received from L. Blanchoin), was stored
in its Ca2+ bound form in Ca-G buffer (5mM Tris-HCl pH 7.5, 0.2mM ATP, 0.2mM
CaCl2 and 0.2mM DTT) at 4˚C. Immediately before polymerization, Ca-ATP-actin
was converted to Mg-ATP-actin by incubation with one-tenth of a volume of 10x
exchange buffer (2mM EGTA and 0.2mM MgCl2) in Mg-G buffer (Ca-G buffer with
addition of 1mM MgCl2) for 5 min at 4°C. The actin was then polymerized by
addition of a 1:9 dilution of 10x KMEI (500mM KCl, 10mM MgCl2, 10mM EGTA,
100mM Tris-HCl, pH 8) (Blanchoin et al., 2000).
After 20 min of polymerization at RT in presence of one molar equivalent rhodamine-
phalloidin, the actin was diluted to a final concentration of ~10nM in fresh
fluorescence buffer (50mM KCl, 1mM MgCl2, 100mM DDT, 20µg/ml catalase,
100µg/ml glucose oxidase, 3mg/ml glucose, 0.5% methylcellulose, 10mM imidazole
pH 7.0). Two microlitres were applied to glass coverslips coated with 0.01% (w/v in
H2O) poly-L-lysine and the actin filaments were viewed with the same microscope as
stated above (DM-RXA, Leica, Germany).
Pyrenyl-actin polymerization assay
Pyrenyl-actin was produced by labeling the Cys374 residue in actin monomers with
pyrene-iodoacetamide. Before polymerization, Ca-ATP-(pyrenyl) actin was converted
to Mg-ATP-(pyrenyl) actin as already described. The (pyrenyl) actin (in general 2µM)
was mixed with the stated proteins at RT in Mg-G buffer, and one-tenth of a volume
of 10x KMEI was added to initiate polymerization. Pyrene fluorescence of samples
(200µl) was monitored using a spectrofluorimeter with excitation at 365 nm and
emission at 407 nm.
Actin polymerization on crude nuclear envelopes and western blot analysis
Rabbit skeletal muscle actin was polymerized, at indicated concentrations, for 30 min
with the protocol described above in the presence of isolated NE-membrane. (Isolated
NE membranes were obtained in collaboration with the group of M. Matunis. The
ghost membranes were prepared according to the protocol in (Cronshaw et al., 2002).)
Aliquots of this reaction mix were then put onto a glass cover-slip, where the nuclei
were let to adhere and then fixed with 4% paraformaldehyde for 20 min, whereupon
Material and Methods
55
immunostaining with mAb414 (Davis and Fink, 1990) (1/5000) and phalloidin-
Alexa488 (Molecular Probes) was performed (see above).
For cosedimentation assays, actin (4µM final) was polymerized in the presence of
isolated NE-membranes (same protocol) followed by a low speed centrifugation with
an Eppendorf 5417C at 1200g. Supernatants were transferred to fresh tubes and
pellets were washed once in 1x KMEI and resuspended in 20µl 1x KMEI. Equal
volumes of the supernatants and the pellets were subjected to western blot analysis.
The different fractions were subjected to SDS-PAGE (10% gel) and immunoblotted
with purified mAb414 (1/5000) or an anti-actin antibody (sigma) (1/1000). To remove
the proteins at the surface of the isolated NE, we incubated the crude NE-membranes
for 1h at 4°C with MgCl2 (2M final) and washed them twice in their conservation
buffer (10% sucrose, 20mM triethanolamine, 0.1mM MgCl2, 1mM DTT, pH 7,5).
After MgCl2 treatment the nuclear envelopes (NEs) were subjected to the co
sedimentation assay described above.
To study the direct interaction of actin with the nuclear membrane, NEs were
additionally pre-incubated overnight at 4°C separately with mAb414 (1/4000), anti
Nuance mAb (directed against an actin binding protein on the nuclear membrane;
1/50) and anti c-myc (Santa-Cruz, Biotechnology; (1/2000)). Cosedimentation assays
and SDS PAGE were then performed as described above, with 2µM actin.
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3. Results
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3.1 Part I: Implication of the host cell in HIV infection
3.1.1 The viral protein R (Vpr) induces nuclear membrane invaginations
In contrast to other retroviruses, lentiviruses are able to infect non-dividing cells.
Despite the importance of this characteristic for HIV infection, the nuclear import of
the PIC (pre-integration complex) is still poorly understood. In addition to the central
DNA flap, several NLS containing-proteins have been proposed as being implicated
in the process (Bukrinsky et al., 1993a; Gallay et al., 1997; Heinzinger et al., 1994;
Popov et al., 1998a; von Schwedler et al., 1994; Zennou et al., 2000). Amongst the
NLS-bearing proteins, the small (14 kDa) Vpr protein (Bukrinsky and Adzhubei,
1999) is a promising candidate. Erroneously, this protein was classified as accessory
yet it turned out to be necessary but not essential for HIV replication in non-dividing
cells. However, the fact that the vpr gene is conserved in primary isolates of HIV-1
strongly suggests a crucial role. As an integral part of viral particles, Vpr is imported
into the cells during infection (Coffin, 1996) and stays associated with the PIC at least
until the genomic DNA is delivered into the nucleus (Miller et al., 1997).
Furthermore, Vpr interacts with POM121 and hGC1, two components of the nuclear
pore complex (NPC) (Fouchier et al., 1998; Le Rouzic et al., 2002). The binding to
the NPC may be important to explain the requirement of Vpr for HIV nuclear import
in non-dividing cells.
The nucleus is separated from the cytoplasm by two concentric membranes known as
the nuclear envelope (NE). The NE is punctuated by holes known as nuclear pore
complexes (NPCs), which provide the main pathway for transport of cellular material
across the nuclear-cytoplasmic boundary. When HeLa cells were transfected with a
vector containing Vpr fused to the green fluorescent protein (GFP), the tagged protein
was clearly localized to the nuclear envelope and more precisely displayed the
characteristic punctuated NPC staining (Figure 9).
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Figure 9: “Z-stack” from nuclear associated Vpr-GFP inside a living HeLa cell.
The panel shows a fluorescent image recorded from the nucleus of a living HeLa cell expressing Vpr-
GFP. Vpr-GFP expression reveals the characteristic punctuated staining of NPCs. Note the membrane
invagination appearing at the bottom of the nucleus. The image series (left to right) shows images
selected at z-axis intervals of 300nm, descending through the sample. The scale bar (bottom right) is
10µm. Images were recorded using a TILL-Photonics imaging system mounted on a Zeiss
Axiovert200M microscope.
The shape of the eukaryotic cell nucleus as defined by the nuclear envelope (NE) is
usually not a smooth symmetric spherical or ovoid shape. Instead, it contains
asymmetric structural domains in the form of deep membrane folds, or
“invaginations”. These structures are widely reported (Bourgeois et al., 1979;
Hochstrasser and Sedat, 1987; Park and De Boni, 1992) and appear to be a common
feature of eukaryotic nuclei.
Using an inverted fluorescent microscope for living cell imaging, Vpr-dependent
deformation of the nuclear envelope could be recorded. Surprisingly, nuclear
membrane ruffling was enhanced compared to control experiments, in which cells
were transfected with the GFP-conjugated nucleoporin POM121 (a transmembrane
nuclear pore complex (NPC) protein). In Vpr expressing cells, we also observed an
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enhanced frequency of nuclear membrane invaginations. We quantified this
observation in fixed cells. Invaginations were counted ~8 hours after transfection with
Vpr-GFP or the control plasmid POM121-GFP. The statistical analysis resulted in a
40% increase of invagination frequency in cells expressing Vpr. Moreover we
observed, that the induction of invaginations was only transient, because invagination
counting after 24 hours following transfection resulted in a non significant increase
(data not shown). From this point forward we conducted in vivo imaging experiments
of Vpr expressing cells at early time points after transfection.
Besides membrane ruffling and the increase of invaginations in fixed cells, we also
recorded highly dynamic processes, with invaginations appearing and disappearing
within few minutes (Figure 10).
Figure 10: Dynamic invagination of nuclear envelope in cell expressing Vpr-GFP
The panel above shows the nucleus of a HeLa cell transiently expressing Vpr-GFP. The cell was
recorded for about 15 minutes on a single plane with one image recorded every 30 seconds. In the first
timeframes the nuclear membrane is rather stable. But then preceded by membrane ruffling at a distinct
area of the NE (indicated by arrowhead in the second frame) a highly dynamic invagination appears
and disappears (arrowheads) within a total time of 3 minutes.
The fast and directed fluctuation of the nuclear membrane observed at a locally
distinct area, is a very interesting observation in the context of the yet unanswered
question of HIV pre-integration complex (PIC) entry into the nucleus. However, the
functions of nuclear membrane invaginations are not well understood. NE
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invaginations appear as fine tubular projections of the double membrane, which
permeate inwards upon the nuclear space, and can exhibit dynamic structural
fluctuations (Broers et al., 1999; Ellenberg et al., 1997; Fricker et al., 1997). To date,
the molecular basis for de novo formation and dynamic structural organization of
invaginations has remained elusive.
3.1.2 Actin-polymerization and NE-membrane structural plasticity
To gain a primary understanding of the structural plasticity and dynamics of nuclear
envelope (NE) membranes we used a paradigm based on the POM121-GFP fusion
protein expressed in Hela cells. Inside fixed cells, NE invaginations were observed as
discrete membrane infolds reaching from the nuclear membrane into the nucleoplasm
(Figure 11).
Figure 11: Nuclear invaginations visualized in fixed cells
Wide field fluorescence images of fixed HeLa cells expressing POM121-GFP co stained with Hoechst.
Two different kinds of invaginations can be shown. In the first two examples (i, ii) invaginations are
seen as large membrane folds and the third panel (iii) highlights an invagination seen as a spot at the
nuclear envelope surface (scale bars: 5µm).
As evidenced by DNA staining (Hoechst labeling), NE-membrane invaginations were
observed mostly in interphase cells, demonstrating that this phenomenon is quite
distinct from mitotic invaginations, which precede the nuclear envelope breakdown
(Beaudouin et al., 2002).
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Depending on the serendipitous point-of-view, the green POM121-GFP channel
allowed NE-membrane invaginations to be observed as distinct striations (Figure 11 (i
& ii)), or isolated points (Figure 11 (iii)) that penetrated through the depth of the
nucleus. Simple three-dimensional image reconstruction and iso-surface rendering
emphasized how these deep membrane folds entered the nucleoplasm (Figure 12).
Figure 12: 3D reconstruction
The reconstruction of a stack (Figure 11 (ii)) shows the projection of the invaginating nuclear envelope
membrane into the nuclear space, and (right) its iso-surface rendering. Note how in the iso-surface
rendering the invagination penetrates deep into the interior of the nucleus.
We made similar observations in a variety of distinct cell types (including NIH-3T3,
BHK1, HEK293, HeLa cells) consistent with the view that the phenomenon is a
common feature of interphase nuclei (Clubb and Locke, 1998; Collings et al., 2000;
Fricker et al., 1997). Next, we proceeded to visualize the dynamics of NE-membrane
structural plasticity using living Hela cells expressing POM121-GFP, and detected
continuous NE-membrane “ruffling”. We also observed rotational nuclear movements
as previously described (Bard et al., 1985; Paddock and Albrecht-Buehler, 1986), but
this global movement of the entire nucleus was distinct and different to the micron-
domain movements associated with NE-membrane ruffling. In addition, a second
major dynamic activity, albeit more rare than NE-membrane ruffling, was the de novo
formation of NE-membrane invaginations. Sometimes, NE-invaginations were highly
transient and disappeared within minutes (Figure 13).
Results
62
Figure 13: Highly dynamic nuclear invagination
Four-dimensional time-lapse recording showing a transient nuclear invagination inside a living HeLa
cell expressing POM121-GFP. The nucleus was “through-focus” imaged (one z-stack every 60
seconds) yielding a z-stack image series over time during 20 minutes. The images are selected from
three different focal planes, at comparable time-points during which a transient invagination appears
during only 1 minute (arrow) and then disappears (scale bar: 5µm).
Evidently, these types of highly localized structural dynamic resembled directed
movements that should most likely be driven by a cellular force-generating
machinery. In this context, previous studies in fixed cells have reported NE-
membrane invaginations to be filled with the candidate force-generating polymer: F-
actin (Clubb and Locke, 1996; Johnson et al., 2003), prompting us to next investigate
the effects of drugs known to modulate the dynamic equilibrium for actin
polymerization inside living cells.
We treated HeLa cells expressing POM121-GFP with drugs that increased
(Cytochalasin D (CD), and Lantruculin A (LatA)), or decreased (Jasplakinolide
(Jaspl)) polymeric actin turnover. Cells were then fixed, and we measured the
percentage of cell nuclei containing invaginations. With this approach, ~20% of cells
possessed an increased occurrence of invaginated nuclei (arbitrary more than two)
following either no-treatment (control) or vehicle (DMSO) treatment. By contrast, the
percentage of cells displaying nuclear invaginations was highly increased following
treatment with either CD, or LatA (~66% and 87% respectively). Treatment with the
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F-actin stabilizing drug Jaspl, led only to a doubled value of cells displaying NE-
membrane invaginations compared to the controls (~41%) (Figure 14).
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Figure 14: “Invaginated phenotype” after treatment with actin drugs in living cells
Hela cells expressing POM121-GFP were treated with the cytoskeleton interfering drugs CD (1µM),
LatA (1µM) and Jaspl (200nM) (additionally vehicle (DMSO) treatment) fixed and co-stained with
Hoechst 33342. In two independent experiments the phenotypes normal/round and invaginated were
counted with n≥200 nuclei per experimental setup.
Taken together, the effect of CD, LatA, and Jaspl on the structure of NE-membranes,
suggests a role for actin polymerization in the formation and/or stability of NE-
membrane invaginations. However, it was surprising to find that both increased and
decreased polymeric actin turnover yielded an increase in the number of cells
displaying invaginations. This suggested a more complex relationship between actin
polymerization and NE-membrane invaginations. Accordingly, to gain insight on this
paradox, we next designed a method to investigate directly the polymerization state of
actin in close vicinity to NE-membranes.
3.1.3 A novel method to probe for actin polymerization in situ
To date, there are only a limited number of probes and methods available to detect
actin inside intact living cells, and none of them specifically target the visualization of
actin polymerization per se. We therefore sought to develop a method allowing actin
polymerization to be detected directly inside intact living cells, with the specific aim
of revealing its association with NE-membranes. We achieved this using a fluorescent
derivative of CD (CD-BODIPY). Inasmuch as CD binds specifically to free-barbed-
ends of growing actin filaments, we reasoned that CD-BODIPY fluorescence should
accumulate preferentially at sites of actin polymerization. To qualify, this approach
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we first established the utility of CD-BODIPY as a fluorescent marker for actin. We
assayed CD-BODIPY fluorescence in solutions containing fully polymerized rabbit
skeletal muscle actin at 10 µM. This is a concentration far beyond the critical
concentration for polymerization (Bonder et al., 1983) where ~100% of available
actin is in the polymeric form (Carlier et al., 1986; Coue et al., 1987). Under these
conditions, a concentration dependent, sigmoidal increase in CD-BODIPY
fluorescence was observed. Similarly, addition of CD-BODIPY to cells that had been
fixed and permeabilized also resulted in a sigmoidal binding curve (Figure 15 (A)).
Together this suggests that the drug binds to a saturable actin-binding site in the
absence of dynamic actin filament turnover. To verify these results we used a second
in vitro assay based upon LatA. LatA specifically binds G-actin (1:1) (Spector et al.,
1989), but not F-actin and the resulting net reduction in available monomers shifts the
steady-state equilibrium towards depolymerization (Coue et al., 1987; Spector et al.,
1989). The presence of LatA in polymerized actin solutions caused a net reduction in
CD-BODIPY fluorescence (Figure 15 (B)). The effect was linear at drug
concentrations between 1-10µM, and half-maximal at ~5µM, reflecting the
stoichiometry expected, and strongly suggesting that CD-BODIPY fluorescence was
directly dependent on binding free-barbed-end actin protomers.
Figure 15: CD-BODIPY binds free-barbed-end actin protomers in vitro
Panel A: Concentration dependence of CD-BODIPY fluorescence in polymerized actin solutions
(heavy dashed line, filled circles). The drug’s dose dependent fluorescence in fixed cells (HEK293) is
also shown (fine dashed line, filled squares). All data are normalized to fluorescence maxima at 1µM
CD-BODIPY. Panel B: Measurement of the concentration dependent effect of LatA on polymerized
actin using CD-BODIPY fluorescence. Data points are normalized to the fluorescence measured in
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unpolymerized samples containing 10µM (ATP actin). Note that CD-BODIPY fluorescence in the
presence of polymerized actin is three-fold higher than that measured in unpolymerized actin solutions.
The concentration of free-barbed-end actin protomers is expected to be a non-linear
function of the total actin concentration and the steady state equilibrium for
polymerization (Korn, 1982; Pollard and Cooper, 1986). In a pure solution of actin
around the critical concentration, the majority of polymeric structures comprises short
filaments and di/tri-meric complexes to which CD can bind. Conversely, actin
concentrations superior to the critical concentration yield a diminution of these
binding sites due to a predominance of long filaments. Based on these properties, we
tested the ability of CD-BODIPY to report more subtle changes in the actin
polymerization state using different concentrations of actin. Accordingly, CD-
BODIPY (50nM) fluorescence peaked in pure solutions of actin at ~1.1µM. This
approaches the critical concentration of actin polymerization expected for a reaction
under similar conditions (Carlier et al., 1986). Furthermore, relative to the total
amount of actin present, the CD-BODIPY fluorescence was diminished at levels at
and above the critical concentration. Yet, the signal was high at levels below the
critical concentration. This strongly suggests that CD-BODIPY fluorescence intensity
was favored under conditions where the availability of free barbed-end protomers
characteristic of polymerizing filaments was high, and not when stable polymerized
F-actin filaments dominated (data not shown).
Our in vitro results indicate that CD-BODIPY shows similar affinity for the free-
barbed-end of actin filaments, analogous to CD. In addition, and also analogous to
CD, CD-BODIPY is hydrophobic, allowing it to permeate cell membranes to give a
facile labeling of intact living cells. Living cells, exposed to low concentrations (1-
20nM) of CD-BODIPY revealed patterns consistent with the fluorescent drug’s
ability to label polymerizing actin structures. In particular, we observed localization in
the peripheral lamellipodia of motile cells, which is a well characterized actin-
polymerization-dependent motile structure. More remarkably, CD-BODIPY labeling
also showed a common fluorescence pattern comprising strong fluorescence
concentrated in the nuclear region of the cytoplasm. A variety of different cell types
was examined this way (including the cell lines NIH-3T3, BHK1, HEK293, HeLa
cells, and human glioblastoma cells U87 and U373), and all showed this particularly
pattern of CD-BODIPY labeling localized to cell nuclei (see Figure 37 in annex).
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3.1.4 Polymerizing actin at the nuclear envelope in vivo
To examine more closely the relationship between CD-BODIPY labeling in the
vicinity of cell nuclei, and specifically at the NE-membrane, we again used a co-
visualization strategy in cells expressing POM121-GFP. In this approach, it was
necessary to use a high-speed spinning-disk confocal imaging microscope (equipped
for z-stack axial sampling of the entire cell volume), followed by image processing
and geometric light reconstruction (deconvolution) in order to maximize three-
dimensional spatial resolution, whilst minimizing out-of-focus light contamination.
Intact living cells expressing POM121-GFP showed a characteristic signal
distribution, comprising punctuate densities (reflecting NPC's) that demarcated
precisely the NE-membrane. On the other hand, the CD-BODIPY staining appeared
mostly to spread in a “patchy” pattern throughout the cell cytoplasm, but highly
concentrated in a polarized region in the perinuclear cytoplasm. Most striking, a sub-
cellular pool of CD-BODIPY labeling was clearly cumulated in a ring around the
nucleus, co-localized with POM121 (Figure 16).
Figure 16: Co-localization of CD-BODIPY at the nuclear envelope of living cells
The panel shows one confocal section through a HeLa cell transiently expressing POM121-GFP
(green), and stained with 50nM CD-BODIPY (red). Note the strong “ring” of CD-BODIPY in the
region of the NE. In addition, a bright field image of the same cell is shown, and a corresponding red-
green merged image confirms the spatial correlation between the NE and the ring of CD-BODIPY
staining (scale bars: 5µm).
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Taking full advantage of the low signal-to-noise and enhanced quality of the
deconvolved confocal imaging method, we measured the extent of co-localization
between CD-BODIPY and POM121 in each planar slice from the z-stack image
series. These results were then analyzed as pixel intensity correlation histograms,
revealing co-localization at the NE above background threshold levels for the entire
stack (Figure 17).
Figure 17: Co-localization analysis
The panel shows the same field as shown in Figure 16, except co-localization is represented by opaque
yellow pixels based on image thresholds indicated by the yellow cut-off line (right) in the scatter gram
of specific pixel intensity correlation (scale bar: 5µm).
These results suggested that NE-membranes were lined with free-barbed-end (i.e.
polymerizing) actin. However, due to the unavoidable uncertainty associated with
semi-quantitative analysis of fluorescence co-localization in such a small cellular sub-
compartment, we sought an additional control. Again capitalizing on our confocal/
deconvolution methodology, we chose to use an approach based upon comparison
with single-cell microinjection of fluorescent actin, and fluorescent dextrans. We
reasoned that a high-turnover pool of actin polymerization in the vicinity of the NE-
membrane should recruit microinjected fluorescent actin conjugates. This would
rapidly become visible due to polymerization-dependent accumulation into this highly
concentrated sub cellular compartment. We tested this, by designing a series of
experiments based on single-cell microinjection of rhodamine-labeled actin into cells
expressing POM121-GFP. As a systematic control we used cytoplasmic
microinjection of rhodamine-labeled 70kD dextran, expected to yield a bulk cytosolic
fluorescent signal, which should be excluded from the cell nucleus. For all conditions,
cells were visualized using high-speed, confocal sampling followed by deconvolution
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and co-localization analysis. With this approach, minutes after the microinjection,
fluorescent actin revealed after three-dimensional analysis of “optical slices” an
accumulation of actin-fluorescence surrounding NE-membranes (Figure 18).
Figure 18: Co-localization of fluorescent actin and the NE inside living cells
HeLa cells transiently expressing pom121-GFP (green) and microinjected with either 10µM actin-
Alexa568 (top rows, red), or 70kDa Dextran-rhodamine (bottom rows, red) were imaged in three-
dimensions using a confocal microscope. The columns correspond to xy, xz and yz optical slice section
views through each cell (scale bars: 5µm).
Semi-quantitative co-localization analysis (summarized in table 3) revealed that NE-
membrane accumulation of both microinjected actin and CD-BODIPY was highly
specific as compared with non-specific co-localization measured using microinjection
of fluorescent 70kD dextran. We therefore, concluded with confidence (table 3), that
NE-membranes in situ are abundantly decorated with actin protomers, comprising
free-barbed ends characteristic of a distinct pool of high-turnover polymerizing actin.
Results
69
         
 Colocalisation channel A Mean value StDev  
   
(pom121 GFP)
     
  
 DextranRho inject 1  8,23  
 DextranRho inject 2 22,56  
 DextranRho inject 3 5,77  
 DextranRho inject 4 10,99  
 DextranRho inject 5  12,17 11,944 5,755  
  
 Actin568 inject 1  52,82  
 Actin568 inject 2 37,32  
 Actin568 inject 3 29,84  
 Actin568 inject 4 38,64  
 Actin568 inject 5  26,82 37,088 9,032  
  
 CD treatment 1  87,48  
 CD treatment 2 63,9  
 CD treatment 3 77,87  
 CD treatment 4 56,64  
 CD treatment 5  55,24 68,226 12,532  
         
Table 3: Specific accumulation of polymeric actin at NE inside living cells
Three-dimensional image stacks of living cells expressing POM121-GFP and co-labeled with actin-
rhodamine, dextran-rhodamine, or CD-BODIPY (exemplified in Figures 16 and 18) were analyzed for
signal co-localization. Values in column two show overall percentage of POM121-GFP signal detected
to be co-localized, and columns three and four show the corresponding mean and standard deviation for
five cells in each condition. A student t-test revealed co-localization with POM121-GFP by dextran-
rhodamine (control) to be significantly different from co-localization detected using either actin or CD-
BODIPY labeling (P<0.01).
3.1.5 Actin polymerization at nuclear envelopes in vitro
Our detection of a perinuclear pool of polymerizing actin raised the question of how
actin polymerization could be physically seeded from nuclear envelopes. To address
this issue, we turned to the use of an in vitro assay. Crude nuclear envelopes, prepared
from rat liver cells were incubated in vitro with G-actin under polymerizing
conditions. Actin polymerization was quenched by fixation of the samples on a
microscope cover-glass. The fixed nuclei were then double-stained using, first,
monoclonal antibody mAb414 (revealing nuclear pore proteins and thereby gross NE
structure) and second phalloidin (Alexa-488, revealing specifically actin filaments,
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but not G-actin). We observed long, polymerized actin filaments protruding outwards
from preparations of nuclei (Figure 19). Interestingly, polymerized filaments were
observed at the surface of NE-membranes even at actin concentrations as low as
0.1µM, an actin concentration some ten-fold inferior to the critical concentration of
polymerization. This is suggesting that NE-membranes are able to enhance
polymerization by reducing the critical concentration for actin polymerization in vitro.
Figure 19: Isolated nuclear envelopes catalyze actin polymerization in vitro
The figure shows pseudo-colored images for the merged fluorescence channels of the isolated nuclei
labeled with mAb414 (red) in the presence of two concentrations (1µM (a) and 0,1µM (b)) of rabbit
skeletal muscle actin labeled with Phalloidin-488 (green), under polymerizing conditions. Note
particularly how actin filaments radiate from nuclei in a corona and that even at 0,1µM actin
concentration there are still filaments attached at the isolated nuclei (scale bars 5µm)
We next adapted our in vitro assay in order to distinguish the specificity of crude NE-
membrane for binding with actin. To this end, actin was polymerized in suspension
with isolated nuclei present, and this was followed by a low speed centrifugation
sufficient to separate crude NE-membrane into the pellet, but leaving soluble G- and
F- actin in the supernatant. A Western-blot analysis of supernatant and pellet fractions
showed that the nuclear pellet fraction co-sediments with high levels of actin, and
confirmed that actin binding to nuclear envelopes had occurred. By contrast, the same
experiment performed using high-salt treated isolated envelopes (to remove surface
proteins from the cytoplasmic NE-membrane surface), inhibited the binding of
polymerized actin (as evidenced by its absence from the nuclear pellet fraction)
(Figure 20 (a)). This is suggesting that actin binding to nuclear envelopes involved
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some protein components, and not non-specific, hydrophilic binding to lipid
membranes.
Following, we investigated candidate proteins possibly involved in the mechanism of
actin recruitment to the NE. Based upon the in vitro biochemical assay, we tested the
ability of the anti-nucleoporin mAb414 to displace actin binding to isolated NE-
membranes. As a control, we used an anti-c-myc antibody and observed that mAb414
caused a strong inhibition of actin recruitment into the nuclear pellet. This is
indicating that in our system actin binds specifically to the cytoplasmic face of the
NE-membrane, via its interaction with one (or more) nucleoporins. Parenthetically,
we also tested the effects of anti-NUANCE Ab (Zhen et al., 2002). NUANCE is a
non-nucleoporin, NE-membrane localized protein that is reported to bind actin, and
enhances actin-polymerization. Incubation with anti-NUANCE antibodies also caused
a net reduction in the total actin signal associated with NE-envelopes, compared with
control conditions, but was much less effective than mAb414 (Figure 20 (b)).
Figure 20: Western Blot analysis of NE/ actin interaction in vitro
Co sedimentation assay (a) (S: Supernatant; P: Pellet), gel-photos show Western blot analysis using
either mAb414 (upper panel), or anti-actin-Ab (lower panel). The first six lanes (a) show
corresponding analysis of S/P results from: isolated NE-membrane alone or actin alone (lower panel),
envelopes plus actin, and finally envelopes pre-treated with 2M MgCl2 and then exposed to
polymerizing actin. (actin concentration here 4µM). In panel (b), pellet-fractions for the co-
sedimentation assay with antibody pre-treated nuclear envelopes followed by actin polymerization
(2µM actin) were shown. The upper panel shows a Western blot revealed with mAb414 and in the
lower panel actin in the same sample. Note the complete displacement of actin recruitment following
pre-treatment with mAb414 (lane2), and the diminished levels of actin binding following pre-
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incubation with αNUANCE mAb, compared with the lack of effect following pre-treatment with c-myc
antibodies
Taken together the results from our in vitro analysis suggest strongly that some direct
interaction occurs between actin and nuclear protein component(s) present on the
cytoplasmic face of intact NE-membranes.
3.1.6 Polymerizing actin is integral to NE-membrane invaginations
Microinjected fluorescent actin was sometimes observed to accumulate at the
“mouth” of NE-invaginations, but was difficult to detect deeper inside NE-membrane
invaginations (Figure 21).
Figure 21: NE-membrane invaginations in actin microinjected living cells
Panel A: Shows an example of a HeLa cell transiently expressing pom121-GFP (green) that was
microinjected with 10µM actin-Alexa568 (red, top row), and imaged in three-dimensions using
confocal microscopy. The columns correspond to xy, xz and yz optical slice section views through the
cell for each channel, and the red-green channel merge (third row). Note that in the x,y a single point
(white cursor in merged image) is observed, but in x,z y,z sections this same structure is seen as a long
fine channel crossing the whole nucleoplasm (white cursors) (scale bars 5µM). Panel B: Three-
dimensional rendering showing x,z projection of detail around the NE-membrane invagination (left).
Note the accumulation of red-fluorescent actin in the mouth of the NE-membrane invagination.
By contrast, CD-BODIPY labeling reached much higher levels, and revealed more
clearly that actin polymerization extends deep into the cytoplasmic confines of the
fine tubular membrane infolds. We took advantage of this fact, in order to co-
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visualize the underlying chromatin in the nuclear matrix, revealing a close association
of chromatin to actin filled invaginations. Moreover, combining CD-BODIPY,
Hoechst and POM121-GFP, NE-membrane invaginations were observed as an
exquisitely organized compartment comprising a fine tube of NE-membrane, around
which chromatin in the nuclear matrix was aligned, and through which cytoplasmic
polymerizing actin permeated the core. Combined with our results showing that
cytoskeletal actin binds directly to NE-membranes and actin’s localization to NE
invaginations fits well with the idea that actin polymerization is the driving force for
the formation of invaginations (Figure 22).
Figure 22: Cytoplasmic actin polymerization extends into nuclear invaginations
surrounded by NPC’s and chromatin
The panel shows images of a BHK1 cell stably expressing POM121-GFP (green), and delineating the
opening of a nuclear invagination observed from above as a ring pattern. The cell was co-labeled with
CD-BODIPY (red) and HOECHST (blue) (scale bar: 5µm). The second row of images are enlarged
from the boxes (dotted line) indicated in the top row, highlighting one of the invaginating structures.
Note how the actin polymerization is clearly delineated to be inside the ring of POM121-GFP labeled
nuclear membrane, and that chromatin labeling reflects this organization (scale bar: 1µm).
These results provide a new basis for the understanding of the dynamic relationship
between cytoskeletal actin and nuclear envelope structure. Primarily, they
demonstrate how a highly localized sub-cellular pool of polymerizing actin is directly
recruited by NE-membranes in situ. Furthermore, these data strongly suggest that
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high-turnover actin, surrounding the NE-membrane, is involved in the formation of
NE-membrane invaginations.
Due to the analogy of these NE-invaginations and those observed after Vpr
expression we investigated the possibility of actin being implicated in the Vpr-
induced NE deformations. Moreover, it has been shown recently that HIV exploits the
cytoskeleton to reach the nucleus (McDonald et al., 2002). Given that Vpr is binding
to nucleoporins, stays associated to the PIC until nuclear entry and is implicated in
NE dynamics (according to our observation), suggests a scenario in which Vpr links
the gap between the cytoskeleton and the NPC to support the nuclear entry.
3.1.7 Interaction of Vpr with actin
We sought to discern the capacity of Vpr to polymerize actin in a complex
experiment. The intracellular pathogenic bacterium, Listeria monocytogenes, captures
the host cell's actin polymerization machinery to assemble a comet tail of actin
filaments and to push itself through the cytoplasm (Dramsi and Cossart, 1998). Only
one defined part of the bacterial membrane protein, ActA, is required for the actin-
based motility (Lasa et al., 1997; Pistor et al., 1995). ActA binds actin monomers,
recruits the Arp 2/3 complex and stimulates actin nucleation (Welch et al., 1998).
Therefore, we attempted to produce recombinant Listeria, in which Vpr replaces the
actin polymerization domain of ActA. Subsequent to this, we wanted to investigate,
whether upon infection of cells, the recombinant bacteria were still capable of
inducing actin polymerization and thus being propelled through the cytoplasm.
Unfortunately, we were not able to obtain the mutated strain, because the engineered
bacteria were not viable. This mortality might be due to the amino acid coding, which
differs substantially between Listeria and the human coding, which is used by HIV.
We decided to change the approach to in vitro assays. The in vitro polymerization of
actin has been extensively studied and therefore several assays to test the impact of
single proteins on actin polymerization exist. First we tested if Vpr coated beads can
form actin comet tails in Xenopus laevis oocyte extracts when a fluorescent analog of
actin (actin-rhodamine) is added in the assay. The coated beads recruited actin at their
surface, yet the fluorescence was dim and no actin comet tails could be seen (data not
shown).
As no clear conclusion could be reached in the bead-assay we switched to a
fluorometric study. Herein, actin polymerization is followed by the change in
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fluorescence intensity of a pyrenyl-labeled form of G-actin (N-(1-
pyrenyl)iodoacetamide labeling). This actin analogue is excited at 365 nm and the
emission can me measured at 407 nm. Upon polymerization of pyrenyl-labeled actin,
the fluorescence intensity is about 25-fold enhanced, due to interactions of the stacked
fluorophores (Kouyama and Mihashi, 1980). Pure actin monomers initiate new
filaments with very low efficiency because formation of dimers and trimers is highly
unfavorable compared with polymer elongation (Pollard and Cooper, 1986). Thus,
cells use other factors to initiate filaments. The Arp2/3 complex, an abundant
assembly of seven subunits (Machesky et al., 1994), is one such factor. As positive
control we utilized the Wiskott-Aldrich syndrome protein (WASP), a key regulator of
cytoskeletal reorganization, and added the necessary nucleation factor Arp2/3 in the
corresponding experiment. In Figure 23, the characteristic actin polymerization curve
for WASP/ Arp2/3 (in green) at an actin concentration of 2µM is shown. The same
diagram shows Vpr (in blue and black; with or without Arp2/3 complex respectively),
the Arp2/3 complex alone (in orange) and actin without any additional proteins (in
red).
Figure 23: In vitro actin polymerization visualized in a pyrene-actin assay
Actin polymerization was visualized by the change in fluorescence emission of pyrene-actin. The green
curve represents the actin polymerization for the strong activator couple WASP/ Apr2/3 complex. The
effect of Vpr with or without the Arp2/3 complex is plotted in blue and black respectively. In red and
orange we plotted the controls for actin alone and actin together with the Arp2/3 complex. Vpr
revealed an effect on the elongation of actin filaments. However, Vpr could not reduce the lag phase of
actin polymerization.
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In parallel, we polymerized actin filaments in the presence of the proteins stated
above. After polymerization was completed, the filaments were visualized following
phalloidin-rhodamine staining under a fluorescence microscope. Both experiments
pointed towards an elongation effect of Vpr on actin. Yet, in both assay we used a
chemically synthesized protein of Vpr. Performing the control experiment it turned
out that the elongation effect was due to a byproduct of peptide syntheses:
trifluoroacetic acid (TFA). Normally the quantity of TFA present should not harm any
experimental setup, but actin polymerization is extremely sensible to pH changes. As
TFA is a very strong acid even traces are enough to change the actin polymerization
behavior. Therefore we could reproduce the plotted effect for Vpr upon addition of
equivalent amounts of TFA to 2µM actin in the pyrenyl-actin assay (data not shown).
Having only the chemically synthesized protein at our disposal to perform in vitro
assays we preferred to concentrate on the in vivo experiments (described in 3.1.2).
3.2.8 Visualization of viral Vpr-GFP particles
To study viral dynamics in vivo and to investigate the interaction of viral particles
with polymerizing actin inside living cells, we developed a novel assay system. The
imaging based strategy allows visualization of early and late events of the
postinfection, preintegration episode of the HIV life cycle. For this purpose HeLa
cells, expressing the laminA protein fused to DsRed, were infected with viral particles
labeled with GFP (obtained from A. Boese; see annex). We followed these particles in
live cell experiments on a high-speed image acquisition, fluorescence microscope
(Figure 24 (A)). After the image acquisition, the particles were tracked using
dedicated software (developed by A. Genovesio). The algorithm of the tracking
program allows to follow in vivo single viral particles in three-dimensions. Figure 24
(A) shows an example, where a viral particle (green spot) was tracked. The particle
was moving in a very directed manner towards the nuclear membrane and
disappeared once it reached in close vicinity the nuclear envelope. The second part of
the figure (Figure 24 (B)) shows a deconvolved and reconstructed stack where several
trajectories of the GFP-labeled particles were traced.
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Figure 24: Tracking of viral particle inside a living cell
HeLa cells expressing the laminA protein in DsRed were infected with fluorescent (GFP-lacI-Vpr)
viral particles. Immediately after infection 4D image acquisition was started and the movement of the
GFP labeled particles was followed. After the experiment the data were deconvolved and a single
particle-tracking algorithm was applied on the image series. In (A) we could track one bright spot on its
very directed way in the cytoplasm towards the nucleus (directly on the microscope images). (B) The
left part shows the trajectories of several viral particles after deconvolution and reconstruction of the
analyzed stack. (B; right) shows a blow-up of the upper two particles close to the nuclear membrane
with the traced trajectories in red and green respectively.
These results are very promising and indicate, that the developed experimental setup
allows the in vivo tracking of viral particles. The aim of the project is now to get more
insight into the routing of the PIC through the cytoplasm and the entry into the
nucleus in the presence and absence of Vpr.
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3.2 Part II: PNAs as candidates for novel antiviral therapies
To test the capacity of PNAs for their antiviral potential, we used two different
systems. On one hand, we wanted to inhibit the replication of HIV. In a second
approach (in collaboration with the laboratory of D. Gonzalez-Dunia at the Pasteur
Institut) we sought to block the viral spread of borna disease virus (BDV). BDV, the
etiological agent of Borna disease, is a nonsegmented negative-strand RNA virus (de
la Torre, 1994; Schneemann et al., 1995) that has the unique property, among
members of the order Mononegavirales, of transcribing and replicating its genome in
the nucleus (Cubitt and de la Torre, 1994). The virus causes neurological disorder of
farm animals (Ludwig et al., 1988) and there is considerable evidence that BDV also
infects humans (Carbone et al., 2001; De La Torre et al., 1996) however this remains
controversial.
3.2.1 Selection of target sequences for antiviral PNAs
For the definition of PNA target sequences in the HIV genome, databases (EMBL and
SWISSprot available at: http://genome.dkfz-heidelberg.de/menu/biounit/) were
searched for sequences highly conserved in different HIV clades. Amongst the
identified sequences, we selected the ones playing an important role in different steps
of the HIV replicative cycle.
The central polypurine tract (cPPT) is an essential element of reverse transcription, as
it is an initiation site of second-strand DNA synthesis (Charneau and Clavel, 1991).
We selected three PNAs to target this region. Another target sequence is located in the
central DNA flap, a 99-nucleotide long strand overlap, which is known to be involved
in the nuclear import of the viral pre-integration complex (PIC) (Zennou et al., 2000).
Finally, we choose a sequence upstream of the cPPT on the DNA (+) strand to inhibit
synthesis of the central DNA flap during reverse transcription.
For the inhibition of late steps in the viral life cycle another set of PNAs was
synthesized, targeting Nef and NCp7 as well as one PNA directed against the start of
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the Gag mRNA. The sequences were chosen, because Nef is required for high viral
loads in the infected host and thus for disease progression (Renkema and Saksela,
2000). NCp7 is involved in the packing of viral RNA into the virion and the budding
at the plasma membrane (Berkowitz et al., 1995; Muriaux et al., 1996). Also,
mutation within the NCp7 proximal zinc finger in the HIV-1 genome is leading to a
lower infectivity of the viral offspring (Ramboarina et al., 1999). Additionally, the
PNAs directed against the cPPT and the central DNA flap were synthesized both in
sense and antisense orientation and may therefore target the viral genome during the
early as well as the late replicative cycle. The PNA sequences were synthesized
according to the HIV-1 LAI isolate, a commonly used laboratory strain.
The borna disease virus (BDV) sequences were selected on the coding region of the
viral glycoprotein (GP) mRNA. Sensitivity to detergents and organic solvents indicate
that BDV is an enveloped virus, a suggestion also supported by electron microscopy
data of cell-released BDV infectious particles (Gonzalez-Dunia et al., 1997; Kohno et
al., 1999; Zimmermann et al., 1994). Viral glycoproteins (GPs) present at the surfaces
of enveloped viruses mediate virus attachment to cell surface receptors, serving as
primary determinants of viral tropism and facilitating penetration by triggering fusion
of the viral envelope with cell membranes. The PNA sequences were chosen
according to the BDV laboratory strain He/80.
As negative control, a random sequence was selected which has been verified to
neither match the HIV-1, BDV nor the human genome (Table 4).
Denotation: Target: Polarization: Sequence:
PNA I cPPT DNA (+) or RNA N-term CAA TCC CCC CTT TTC TTT C-term
PNA II cPPT DNA (-) N-term GTA TTC ATC CAC AAT TTT C-term
PNA II long cPPT DNA (-) N-term GCA GTA TTC ATC CAC AAT TTT C-term
PNA III cPPT DNA (+) N-term AAA TTG TGG ATG AAT ACT C-term
PNA III long cPPT DNA (+) N-term AAA ATT GTG GAT GAA TAC TGC C-term
PNA IVa DNA flap DNA (-) N-term TAG TAG ACA TAA TAG CAA C-term
PNA IVb DNA flap DNA (+) N-term TCC CCT GCA CTG TAC CCC C-term
PNA Va Nef DNA (-) N-term AGA TCT TAG CCA CTT TTT C-term
PNA Va long Nef DNA (-) N-term TGT AGA TCT TAG CCA CTT TTT C-term
PNA Vb Nef DNA (-) N-term GGC TAA TTC ACT CCC AAC C-term
PNA Vc Nef DNA (-) N-term TAG AGA TTT TCC ACA CTG C-term
PNA VI start of gag mRNA N-term cac cca tct ctc tcc ttc C-term
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PNA VIIa NCp7 DNA (-) N-term ATT ACT ACG TCT CTC CGT C-term
PNA VIIb NCp7 DNA (-) N-term TAT CGG TTT TTA ACG TCC C-term
PNA Random N-term CAT ACT TGA CTC GTT ATC C-term
PNA-G I G protein RNA N term-GCA TTG CCA GAC TAC CCC C-term
PNA-G II G protein RNA N term-TCC CTA CGC CGC CTT CTC C-term
Table 4: Sequences of the designed and synthesized PNAs
The table shows a list of the 14 PNAs (I-VII), used for either antigene or antisense therapy against
HIV, with the corresponding target in the HIV-1 genome, their polarization and nucleotide sequences.
Also listed is the sequence of the Random PNA as well as two PNAs targeting the mRNA of the BDV
glycoprotein (GP).
3.2.2 PNA synthesis and quality control
All PNAs were synthesized based on the Fmoc chemistry. They were individually
coupled to cellular targeting sequences. PNAs intended to bind to the DNA (-) strand,
in the case of HIV, were synthesized directly with a NLS [SV40-T] sequence that
ensures an efficient nuclear import. The same holds true for the BDV molecules,
because the virus is transcribed and replicated in the nucleus. Cellular import of all
hybrid molecules was achieved by coupling to a cell-penetrating peptide (CCP), the
transport peptide of the Antennapedia homeoprotein in Drosophila (pAntp) (see
chapter 1.2.3) that was synthesized in parallel and coupled via a cleavable disulfide
bond to the purified PNAs. To be specific, antisense molecules need to be at least 15
nucleotides long. However, due to poor synthesis efficiency, the length of PNAs is
still limited. After optimization of our protocol we could ensure the syntheses of
18mer PNAs with a good yield. As the monomer coupling was directly monitored
during synthesis, we could even achieve some PNAs with a good yield up to 21
nucleotides (Table 3). Thereafter, the molecules were purified on an analytical HPLC
followed by laser desorption mass spectrometry to ensure purity of the final product
(data not shown).
3.2.3 PNAs targeting the early replicative cycle of HIV
To investigate effects of PNAs on the early viral life cycle, we used the Hela P4
CD4+/CCR5 (HP4) cell line. This derivative of the HeLa cell line stably expresses the
CD4 and CCR5 proteins crucial for HIV entry into the cell. Furthermore, they carry
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the bacterial lacZ gene under the control of the HIV-1 promotor (LTR) (Charneau et
al., 1994). The LacZ gene encodes an enzyme (β-galactosidase) that can produce a
variety of colored or fluorescent compounds from appropriate substrates. The HP4
cells display low basal β-galactosidase expression, which is dramatically induced by
the HIV-1 transactivator Tat. In this system, the β-galactosidase activity measured
using a chemiluminescent assay is proportional to the amount of Tat protein produced
by the integrated provirus. Accordingly, this assay is a readout of the efficiency of
provirus establishment. If PNAs are able to inhibit early steps of viral replication, less
integration events are expected and thus a lower level of ß-galactosidase activity in
PNA treated cells compared to control or vehicle treatment (HIV-1 only or Random
PNA treatment).
In the first set of experiments, PNAs resuspended in PBS were applied to the cells at
different concentrations ([10pM], [100pM] and [1nM]) half an hour prior to infection
with HIV-1 (LAI isolate). The ß-galactosidase activity was measured 48 hours after
treatment. In HP4 cells treated at a 1nM concentration of the antisense molecules, we
detected a 20-30% decrease in the ß- galactosidase readout for target sequences in the
cPPT (red dashed bars: PNA I Cys/NLS and PNA II Cys/NLS; Figure 25).
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Figure 25: PNA treatment with low concentrations targeting the early HIV life cycle
The ß-Galactosidase readout of 1nM PNA treatment directed against early targets in the HIV life cycle.
The experiment was done in triplicate for each data point. The ß-Gal level of cells treated with PNAs
targeting the cPPT (red dashed bars) was reduced by 20-30% compared to the control (HIV-1 only).
For all other tested PNAs we could not decrease the ß-Gal level in this first experiment.
Increasing the PNA concentrations up to 100nM did not improve the inhibition of
early HIV integration events detected in the first experiment (data not shown).
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3.1.4 PNAs targeting the late replicative cycle of HIV
The following set of experiments intended to study inhibitory effects of the PNAs on
late replicative steps. A population of persistently infected HP4 cells was selected
following infection with HIV-1 LAI. These cells were treated with the 14 PNAs
directed against HIV and the Random PNA at two different concentrations ([100nM]
and [1µM]). After incubation for 48 hours, an aliquot of the culture supernatant was
tested for the amount of released HIV virions by an HIV-1 core profile enzyme-linked
immunosorbent assay (ELISA) quantifying the amount of p24 capsid protein (Figure
26).
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Figure 26: PNA treatment targeting late replicative cycle
Persistently (HIV-1) infected cells were treated with a PNA concentration at 100nM. After 48 hours of
incubation time at 37˚C the viral offspring was detected with a p24 ELISA. Under these conditions
some PNAs (IVb targeting the c-PPT, Vb targeting Nef and VIIa targeting Ncp7), inhibited to a certain
amount the viral production compared to control and vehicle treatment.
In this screen, PNA IVb (targeting the central DNA flap), PNA Vb-NLS (targeting
Nef) and PNA VIIa (targeting NCp7) turned out to be the most promising inhibitors
of the viral production. They decreased the p24 level following treatment with a
PNA-concentration of [100nM] by about 65%, 40% and 30% respectively. All other
PNA sequences tested revealed a p24 level comparable to the vehicle treatment
(Random PNA) (Figure 26). At higher concentrations [1µM] the overall p24 level
was reduced for all PNAs. Unfortunately, this included the Random PNA treatment,
which indicates an unspecific effect of the antisense molecules itself. However, again
the same PNAs (IVb and Vb NLS) showed the best inhibition (data not shown).
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We varied several parameters such as PNA concentration (from 100nM up to 50µM)
or incubation time (24 to 144 hours) for the most promising candidates to ensure a
complete tracing of the viral offspring following PNA treatment. The up-scaling of
PNA concentrations lead to a dose dependant decrease of the viral production, yet
again the same was true for the Random PNAs. We presumed that at some point this
unspecific effect could be titrated out, but the ratio (targeted PNA/ Random PNA)
remained comparable throughout all experiments. Increasing incubation time did also
not result in better inhibitory effect (data not shown).
3.2.5 Infectivity test of produced viral particles
Next, we proceeded to test the infectivity of the viral offspring produced under PNA
treatment. The persistently infected cells were treated twice during a three-day
interval with different PNAs at high PNA concentrations (25µM and 50µM). As an
additional control, we included the BDV PNA-G I to the experiment. After six days,
supernatants were collected and the viral production quantified by a p24 ELISA.
Subsequently, fresh HeLa P4 cells were infected with the same viral titer. As the
viruses applied on the HeLa reporter cells were produced under PNA treatment, we
expected a decrease of infectivity and therefore a lowering of the β-galactosidase
activity in the test system (Figure 27).
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Figure 27: Infectivity test of viral particles
Under permanent PNA [50µM] treatment viral particles were produced in persistently infected HeLa
P4 cells and subsequently used to infect naïve cells. This experiment aimed to test the virulence of a
progeny produced under a PNA repression situation. The amount of integration events measured with
the ß-Gal readout was reduced but none of the samples was completely cleared of viral particles.
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Consistent with the result of earlier experiments, the PNA inhibiting the synthesis of
the central DNA flap (IVb) revealed a decreased infectivity of the viral particles,
produced under PNA repression, of 70% compared to the control. Also PNA I NLS
(targeting the cPPT) and PNA Va (targeting Nef) treatment led to the production of
viral offspring, that showed only 40% infectivity in the ß-Gal readout, compared to
the controls. All other tested PNAs had no significant impact on the infectivity of
virus collected from these cells.
3.1.6 PNA treatment inhibiting borna disease virus (BDV)
BDV infection is noncytolytic in all cell systems examined so far and requires cell-
cell contact for its spread. Little infectious virus is released from BDV-infected cells
(Carbone et al., 1993), and virus yields are very low. In addition, assembled virus is
very rarely observed in infected cells and assembled viral particles have never been
visualized in the brains of BDV-infected animals. BDV antigen distribution in the
central nervous systems (CNS) of infected animals strongly suggests that BDV
disseminates by cell-cell contact, possibly using the synaptic contacts between
neurons (Gosztonyi and Ludwig, 1995). These observations, combined with the
notion that ribonucleoproteins (RNP) of BDV are infectious after transfection to
susceptible cells (Cubitt and de la Torre, 1994), have led to the hypothesis that
dissemination of BDV in the CNS takes place as non-enveloped RNP rather than as
enveloped viral particles (Gosztonyi et al., 1993). This would imply that after initial
entry of BDV into its target cell, BDV glycoproteins (GPs) are dispensable for BDV
dissemination.
To assess whether BDV-GP is required for neuronal dissemination of the virus, a
PNA antisense approach was used. First, we analyzed whether treatment with PNAs
targeted against the coding GP mRNA would lead to decreased expression levels in
infected cells. In order to be able to analyze the expression levels of GP by flow
cytometry, we treated Vero-BV (Vero cells persistently infected with BDV) cells with
PNA constructs (BDV PNAs and Random PNA; Table 3). Due to the persistent
nature of BDV infection in Vero-BV cells, the cells contained considerable levels of
BDV-GP at the start of treatment. Since the half-life of BDV-GP is unknown, we
chose to treat Vero-BV cells for a period of 12 days before analysis. The analysis
demonstrated that upon treatment with PNA-G I, BDV-GP expression levels in Vero-
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BV cells were decreased, whereas treatment with Random PNA and PNA-G II had no
detectable effect (data not shown).
Next, we tested the potential of PNA treatment to inhibit BDV dissemination in
acutely infected primary neurons. One day after initial infection with BDV-CRV
(cell-released virus), neurons were thoroughly washed, and 1 day later, PNAs were
added to the culture medium. Immunofluorescence analysis on day 10 revealed
productive virus spread when cells were treated with the Random PNA, comparable
to the amount of virus dissemination seen in untreated cells (Figure 28).
Figure 28: PNA treatment of primary hippocampal neurons following BDV infection
Primary hippocampal neurons were infected with 250 FFU (focus-forming units) of BDV-CRV/well on
day 3 of culture. On day 4, the cultures were washed twice with fresh medium, after which new
medium was added. On day 5 of culture, PNAs were added (A: untreated; B: Random PNA 0.5µM; C:
PNA-G I 0.5µM). On day 10, samples were taken for immunofluorescence analysis and quantification.
BDV-N was detected with a FITC-labeled secondary antibody and the neuronal staining was achieved
with an anti-microtubule-associated protein 2 (anti-MAP-2) antibody, detected with a CY-3 secondary
antibody. Original magnification x100.
In sharp contrast BDV dissemination was progressively inhibited with increasing
concentrations of PNA-G I, as could also be confirmed by quantification of the BDV-
N-positive neurons per well. The neurons were treated according to the same protocol
as described above, immunostained, and then the number of infected neurons per well
was counted on fluorescent microscopy images (as shown in Figure 28). The
distribution pattern of the few BDV-positive neurons following PNA-G I treatment at
[1µM] suggested that infection of these neurons was due to primary infection rather
than to virus dissemination (Figure 29) (Bajramovic et al., 2003).
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Figure 29: Quantification of inhibitory effect in infected neurons
Quantification of BDV-N-positive neurons per well on day 10 of culture. NT, not treated. Results are
given for one representative experiment selected from a series of three independent experiments.
In summary we could show, that the BDV-GP is necessary for BDV dissemination in
neurons. Furthermore we demonstrated that PNAs directed against the viral mRNA
can efficiently inhibit viral spread in permanently infected cells as well as in primary
hippocampal neurons. Given the low expression level of BDV-GP and its crucial role
in viral dissemination in neurons, this protein represents an attractive target for
antiviral therapy by PNA based strategies.
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My thesis work has been partitioned in two parts. Both were aiming at the
understanding and inhibition of viral propagation. The first part, I will discuss, was
focused on basic cellular biology to get new insights into the host-pathogen
relationship. Secondly we evaluated a novel class of antiviral compounds based on
PNAs.
The human immunodeficiency virus (HIV) manipulates fundamental host cell
processes in sophisticated ways to achieve optimum replicative efficiency. Detailed
analysis of the interplay between viral proteins and normal cellular activities has
provided new insights into central questions of virology and host cell biology.
Many aspects of the HIV-1 life cycle remain largely unknown. Thus, little is
understood of the events occurring immediately after entry into the cytoplasm by
membrane fusion. This implies routing, decapsidation and nuclear import of the pre-
integration complex (PIC). In addition to the inferred engagement of the classical
nuclear import pathway (which utilizes importin-α and importin-ß), it appears that
Vpr acts in a complementary fashion to augment PIC import. In particular, Vpr
contains a NLS sequence and is able to interact with importin-α as well as with
nucleoporins (Fouchier et al., 1998; Le Rouzic et al., 2002; Popov et al., 1998b), and
may therefore serve to directly connect the PICs to the nuclear pore complex (NPC).
Upon transfection of HeLa cells with Vpr-GFP, the characteristic punctuated pattern
of the NPC was stained after short expression time of the plasmid. The over
expression of the viral protein induced the incidence of nuclear envelope (NE)
membrane invaginations significantly. Moreover we recorded some of the
invaginations being very fast, pushing into the nucleoplasm and disappearing within
few minutes. These highly dynamic appearances are fairly rare, yet we also observed
in all experiments enhanced membrane ruffling at the nuclear envelope (NE). Since
membrane ruffling is easier to analyze than the rare but highly dynamic invaginations
we are about to quantify the observation in Vpr-expressing cells compared to control
conditions (see annex).
Recently, it has been shown, that Vpr can induce ruptures of the nuclear envelope that
may constitute an alternative mechanism evolved by HIV to get access to the nucleus
(de Noronha et al., 2001). In this context the induction of invaginations is highly
intriguing, as this could precede the NE ruptures. NE invaginations have been
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described before and seem to be a common feature of cell nuclei in mammalian
(Beaudouin et al., 2002; Ellenberg et al., 1997), plant (Collings et al., 2000) and insect
cells (Hochstrasser and Sedat, 1987). However little is known about the function and
formation of NE invaginations. Therefore we investigated this common cellular
phenomenon to get further insight on this possible mechanism involved in the nuclear
import of HIV.
In interphase cells we observed nuclear membrane ruffling and nuclear invaginations
being either stable and durable over time or in contrast highly active. Thus actin
polymerization provides a good candidate for the molecular force generating
mechanism that must exist to drive nuclear membrane dynamics. Due to the abundant
amount of actin inside living cells we could show, only with state-of-the-art imaging
techniques using spinning disc confocal acquisitions followed by deconvolution, that
CD-BODIPY as well as microinjected monomeric actin is immediately localized in a
fine ring around the nuclear envelope. Furthermore, actin co-localizes in a significant
degree with the NE and is localized deep inside membrane invaginations. Due to CD-
BODIPY labeling (respective the free-barbed-ends) the visualized actin was
comprised, not from stable filaments, but rather from high-turnover polymerizing
actin. These observations provide the first evidence that dynamic nuclear membrane
invaginations depend on actin polymerization. This mechanism would be envisaged
analogous to the established model describing plasma-membrane filopodia
(microspike) formation (Mallavarapu and Mitchison, 1999; Small et al., 1978; Wang,
1985).
Filopodia are tiny extensions, protruding from the surface at the leading edge of the
plasma membrane (Jacinto and Wolpert, 2001; Vacquier, 1968). They have
dimensions comparable to that of the nuclear invaginations reported here. The
necessary force generation for these structures comes from compartmentalized actin
treadmilling (for review see (Welch and Mullins, 2002)). In this context stable NE-
membrane invaginations could arise from a cascade of events beginning with
enhanced actin polymerization at a highly localized site on the cytoplasmic surface of
the NE-membrane (Figure 30). Qualitatively this activity results in membrane
“ruffling”, which manifests as a restricted and dynamic deformation of the NE.
Subsequently, dynamic ruffling can propagate into a rapid (minutes) de novo
generation of conspicuous, finger-like projections (invaginations), which either
collapse in minutes, or stabilize sufficiently to last many hours.
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Since many years it has been recognized that de novo actin polymerization happens at
membrane surfaces (Tilney, 1976). In existing models it has been observed that free-
barbed-ends are attached to the membranes and filament growth happens to be at the
same site (Defacque et al., 2000; Mitchison and Cramer, 1996; Small et al., 1995;
Tilney and Portnoy, 1989). Accepting this precedent would imply that the free-
barbed-ends of polymerizing actin in NE-membrane invaginations are also oriented
towards the membrane and thus at the tip of the forming structure (Figure 30).
Figure 30: Scheme for de novo generation of nuclear membrane invaginations
Such explicit polarization requires a complexity of molecular players. In filopodia
formation, the small GTPase Cdc42 is the major activator of polymerization (Ridley
and Hall, 1992; Ridley et al., 1992) through numerous downstream effectors
including members of the Wiskott-Aldrich syndrome protein family (WASP/N-
WASP) (Symons et al., 1996), the membrane phospholipids phosphatidylinositol 4,5
bisphosphate (PIP2) (Yin and Stull, 1999) and the Arp2/3 complex (Higgs and
Pollard, 2000). In NE-membranes it is not yet clear whether the same molecules are
involved. On this point, it is striking that Cdc42 is remarkably concentrated in a
perinuclear ring pattern around the nucleus (Luna et al., 2002). Therefore this would
be an interesting candidate to investigate the molecular components involved in NE
dynamics.
We also found that nucleoporins, themselves are responsible for actin binding. This
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could be the basis for stabilization and/ or propagation of NE-membrane
invaginations. However, previous studies showed that NPC channel permeability is
directly modified by the polymerization state and binding of actin (Prat and Cantiello,
1996). Moreover, knockout of a divergent actin gene (ACT2) in yeast yields defects
in NPC structure and function (Yan et al., 1997). Such evidence suggests that actin
binding to the NPC can result in structure/ function modulation. Actin-bound NPC’s
could thereby be structurally primed to answer functional requirements inside the
nuclear milieu, for example, with respect to chromatin metabolism. Towards this view
our visualization of chromatin deposits surrounding NE-membrane invaginations
might prove to be of profound significance. Our results reveal a striking association
between discrete NE-membrane invaginations and the underlying chromatin. It has
been suggested that NE-membrane invaginations may play a role in the spatial
organization of the NE/chromatin interface (Ellenberg et al., 1997). Furthermore this
has been supported by the fact that an increased electron density similar to
heterochromatin surrounds nuclear membrane invaginations (Ellenberg et al., 1997;
Fricker et al., 1997) and membrane ‘tracks’ associated with nucleoli (Bourgeois et al.,
1979; Dupuy-Coin et al., 1986). We suggest that functionally distinct NE-membrane
invaginations could be encoded, in a spatially compartmentalized manner, to serve for
better functions concerning the interplay of nucleo-cytoplasmic transport and
communication.
Since actin treadmilling is involved in the shaping of the nuclear envelope this may
also hold true for the Vpr-dependent invaginations. Possibly, Vpr could enhance the
actin polymerization at the NE to increase the frequency of the dynamic phenomenon
observed. Inducing invaginations would situate the PIC in close vicinity of a high
NPC density and thus the underlying chromatin, which we have demonstrated to be
associated.
We hypothesized that Vpr may interact directly with actin such as a nucleation factor.
However, we could not show a direct interaction of Vpr with actin. The in vivo actin
polymerization machinery is a very complex and equilibrated system. Therefore it
might be possible that the interplay involves a third party, which has not been present
in the in vitro experiments. We could show that the NPC is involved in actin
recruitment to NE-membrane and furthermore it has been demonstrated that Vpr
binds to nucleoporins. This connection might well be the key for the induction of
actin polymerization. For the moment we have no evidence for this interaction being
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responsible for actin polymerization initiation. However, this would be an important
issue to address, in order to find new approaches to inhibit HIV infection.
Since the discovery of HIV about twenty years ago, extensive research on the viral
lifecycle has transformed AIDS in a treatable yet not curable disease. Introduction of
triple combination therapy, comprising protease and reverse transcriptase inhibitors,
markedly reduced mortality of AIDS patients in industrialized countries. However,
the virus is able to escape highly active antiretroviral therapy (HAART) due to the
emergence of resistant strains (Pomerantz and Horn, 2003).
HIV infection typically results in high replication of virus with innocuous symptoms
followed by a clinically latent period (which is variable depending on the infected
individuals). The ability of the virus to reach and infect immunologically privileged
sites such as brain and lymph nodes (Haggerty and Stevenson, 1991) complicates the
treatment of HIV due to the poor accessibility of these compartments for drugs
(Thomas, 2004). Latently infected resting CD4+ T lymphocytes can survive for many
years and cause re-emergence of virus after withdrawal of HAART (Finzi et al., 1997;
Wong et al., 1997). These sanctuaries constitute a major obstacle for virus eradication
in infected individuals, because currently used drugs can only fight HIV while the
virus is replicating. The frequent occurrence of adverse effects and metabolic
complication directly related to therapy as well as the high economic costs of HAART
call for further development of HIV therapies. Therefore a PNA based antisense
strategy could be a complement for currently available drugs. PNAs can target early
and late replicative steps, thus block de novo infection and viral spread.
We designed a series of PNAs against HIV with a broad spectrum of target sequences.
The length, although challenging for PNA syntheses, is important for the specificity
of antisense molecules. Specific binding is achieved with 14-15mer PNAs however
for strong inhibition longer PNAs are favorable (Doyle et al., 2001). Optimization of
the chemical synthesis allowed us to obtain 18 to 21mer PNAs. Furthermore the
efficient cellular and nuclear import of our PNA constructs, due to the attached pAntp
peptide and a NLS sequence, has been verified recently (Braun et al., 2002).
The experimental settings to evaluate the virtue of the PNAs were chosen in order to
be able to distinguish between effects on early and late replicative cycle. We tested
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the PNA treatment upon acute HIV infection as well as on persistently infected cells.
Experiments on the persistently infected cells put forth some PNAs with inhibitory
potential. At a concentration of 100nM PNAs targeting the central DNA flap, Nef and
NCp7 caused an up to 3-fold reduction of the viral load in the cell culture
supernatants. We also applied a cocktail of the three PNAs stated above to see if a
concerted action of the most promising PNAs resulted in a better inhibition. Yet the
effect was not significantly improved (data not shown). Following, we increased the
PNA concentrations (up to 50µM), what conducted to further lowered levels of
detected p24 antigen. Yet beside this dose response relationship, we noted an
unspecific effect of the random PNAs upon up scaling of the concentrations above
1µM. The ratio of specific effect versus unspecific random PNA effect stayed the
same with increasing concentrations. Thus the inhibition of the antisense molecules
was significantly narrowed in comparison to the random PNAs.
The best effects could be achieved while testing the infectivity of viral particles
produced under PNA treatment. We expected NCp7 and Nef to be potent targets
because defects in both proteins are known to produce less infective viruses (Ottmann
et al., 1995; Schiavoni et al., 2004). Yet the NCp7 PNA had no significant effect
however the PNA targeting Nef decreased the ß-Gal readout level to about 40%.
Surprisingly, after treatment with the anti flap PNA the viral particles were 3-times
less infectious. This is an interesting result, because testing the same PNA for its
inhibitory effect in early replicative events showed no significant results. Thus the
result could indicate that the PNA binds to the viral RNA before budding and inhibits
viral infection in the next replicative round. If the binding of PNAs inside mature
particles decreases infectivity, it would be attractive to synthesis PNAs with a viral
targeting signal. Vpr is recruited through the interaction with p6 of Gag to the viral
particle (see introduction). Therefore in analogy to cell-penetrating peptides (CCPs) it
might be possible to target PNAs directly to budding viral particles. Following,
infectivity of these viral particles could be tested in primary lymphocytes, the
principal targets for HIV-1 in vivo, which are poor substrates for transfection.
The experiments designed to inhibit early events in the HIV life cycle were not very
successful. Lack of effectiveness observed may be a result of inaccessible sites in the
target. The secondary structure of the RNA plays a crucial role in the competence of
the treatment. Additionally the viral RNA is coated with 1500-2000 copies of NCp7
(Darlix et al., 1995), protecting the genomic RNA against degradation by RNAses
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(Tanchou et al., 1995). Traditionally antisense design has been based on the principle
of trial and error. This can often be a laborious process considering that only an
estimated 2-5% of randomly selected sites represent competent antisense targets (for
review see (Sohail and Southern, 2000)).
Recently it has been shown that an effective PNA antisense inhibition of HIV is very
challenging. Targeting different regions of the HIV-1 genome by complementary 15-
mer PNAs revealed that one antisense oligomer out of 22 was potent in inhibiting the
viral protein synthesis and virion assembly (Sei et al., 2000). A PNA targeted against
the gag-pol mRNA transframe region reduced HIV-1 p24 antigen production in the
culture supernatant by up to 98%. Additionally PNAs are extremely sensible to
mismatches. The introduction of one or two mismatches abolished the inhibition of a
18mer PNA shown to inhibit gene expression in a luciferase gene reporter system
(Doyle et al., 2001). This evidence complicates a PNA based therapy against HIV,
due to its high variability which is resulting of reverse transcriptase infidelity, having
an average error rate per detectable nucleotide incorporated of 1/1700 (Roberts et al.,
1988).
Since small interfering RNAs (siRNA) can be used in a sequence specific manner for
gene silencing in mammalian cells, they offer a good tool for intracellular
immunization against HIV. Only the unsolved problem of in vivo delivery constitutes
a major drawback versus the PNA treatment. However, it has been shown that HIV
replication can be inhibited by a RNAi approach (Arteaga et al., 2003; Coburn and
Cullen, 2002; Jacque et al., 2002). Das et al. demonstrated that a siRNA targeted
against Nef blocked HIV replication in persistently infected cells. Yet, after several
weeks of cell culture HIV-1 escape variants appeared, no longer inhibited by siRNA
(Das et al., 2004). Even targeting essential viral genes with an antisense approach, the
virus may become resistant as a result of silent mutations. Therefore targeting of
cellular genes as the coreceptor for membrane fusion CCR5 or Cyclophilin A, an
intracellular chaperone essential for infectivity, could be advantageous (Liu et al.,
1996; Towers et al., 2003).
With the large spectrum of antisense/ antigen molecules directed against HIV, we
wanted to cover several sensible targets for a possible therapy purpose. We could
show promising effects upon treatment with some PNAs however for an anti-HIV
therapy the inhibition was not strong enough. Additionally, a sequence specific
antisense strategy targeting single HIV sequences is, due to the high mutation rate,
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very challenging. As it has been shown, an antisense treatment can result in the
inhibition of viral replication but it is likely followed by viral escape (Das et al.,
2004). Yet, analogous to the current triple combination therapy a PNA based
treatment could be administrated in combination to existing drugs or as a cocktail of
different PNAs to prevent viral escape.
In contrast to HIV, the PNA based approach seems more potent to inhibit viral spread
of borna disease virus (BDV). Although BDV is like HIV a RNA virus, yet it is not
replicating via a DNA intermediate. The BDV genome is very stable, with less than
5% sequence differences in isolated strains (Binz et al., 1994; Schneider et al., 1994).
This low mutation rate is highly favorable for an antisense inhibition of the virus.
We tested 2 different sequences targeted against the surface glycoprotein (GP) of
BDV. Not much is known about the function of this protein. Electron microscopy data
suggest that BDV is an enveloped virus (Gonzalez-Dunia et al., 1997; Zimmermann
et al., 1994), however assembled particles have never been visualized in the brain of
infected animals. We assessed whether the GP is required for viral dissemination. For
this purpose the PNA approach represented a molecular biology tool to study the
function of GP in the viral life cycle. Yet the efficient inhibition of viral spread opens
the possibility of a sequence specific, PNA based, anti-viral therapy.
Although the choice of target sequences is a very delicate issue (discussed above) one
of the two synthesized PNAs efficiently down regulated the GP expression. The same
PNA was also potent to inhibit viral spread in an experimental system using
persistently infected Vero cells as well as in primary hippocampal neurons. This result
gives further evidences that enveloped viral particles are essential for BDV
dissemination.
In vivo, BDV replicates and persists predominantly in neurons of the limbic system.
Therefore the primary cultures of rat hippocampal neurons are an appropriate assay
system to study primary infection. The efficiency of the PNA treatment in these cells
is encouraging for a possible therapeutically approach. Expression level of GP in vivo
is very low (Carbone et al., 1993) and with its crucial role for viral spread in neurons,
the BDV-GP represents an attractive target for antiviral therapy by antisense
strategies. Moreover well studied animal models are available to investigate BDV
infection. Rats and mice can be infected experimentally, which represents a powerful
tool to further investigate the potential of a PNA based antiviral therapy.
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5.1 Abstract (english):
The human immunodeficiency virus (HIV) is the causative agent of the acquired
immunodeficiency syndrome (AIDS). Despite more than twenty years of intense research still
no vaccine or curing therapy has been found. For the development of novel antiviral
compounds, understanding of the HIV lifecycle as well as the molecular mechanisms of host
pathogen interactions are a prerequisite.
Like all viruses, HIV subcontracts cellular machineries for efficient replication and
production of new progeny. A particular feature of lentiviruses is the active transport of the
pre-integration complex (PIC) into the nucleus. The mechanism remains elusive, yet in the
case of HIV the viral protein R (Vpr), a small 14kDa accessory protein, is one candidate
possibly implicated in the process. The protein stays associated to the PIC until nuclear
translocation. Furthermore it has been shown, that Vpr binds to the nuclear pore complex
(NPC). This interaction might therefore be the link mediating nuclear import of the PIC.
Moreover the cytoskeleton has been shown to play a major role in cytoplasmic transport of
viral particles. In this context, we observed the nuclear envelope (NE) to be embedded in a
perinuclear actin shell and displaying highly dynamic nuclear invaginations. We developed a
novel approach to visualize actin inside living cells based on a fluorescent analog of
cytochalasin D (CD-BODIPY). Due to specific binding to free-barbed-ends of short actin
fibers, we could show that this compound visualizes a high turnover actin pool around the NE
and inside NE-membrane invaginations of living cells. Although reported in many different
cell types, the possible role of perinuclear actin filaments in the dynamic structural plasticity
of the NE remains unresolved. We could show that NE-membranes alone are sufficient to
nucleate polymerizing actin filaments in vitro, involving both actin recruitment to their
surface, and filament growth. Accordingly, our results demonstrate that perinuclear actin
dynamics are orchestrated by the NE itself. Therefore, by binding of Vpr to the NPC, the
virus could possibly exploit this pool of polymerizing actin as a new strategy to overcome the
nuclear membrane.
Furthermore, we tested peptide nucleic acids (PNAs) as new compounds to inhibit viral
spread at different stages of the lifecycle. PNAs have been developed recently and dispose of
several features to be a powerful tool for a novel antisense approach. We synthesized a series
of PNAs directed against crucial sequences in the HIV genome and tested them under various
conditions. This showed in particular, that infectivity of virions produced in the presence of
PNAs was significantly diminished. In another viral system, PNAs targeted against the borna
disease virus (BDV), could provide evidence for the requirement of the surface glycoprotein
(GP) in BDV infection. Moreover, the treatment could effectively inhibit viral spread in
primary neurons. These results demonstrate PNAs to be a powerful molecular tool and a
potential antiviral drug candidate.
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5.2 Zusammenfassung (deutsch)
Das Humane Immundefizienzvirus (HIV) ist der Auslöser der erworbenen
Immunschwächekrankheit (AIDS). Seit mehr als zwanzig Jahren wird intensive Forschung
betrieben, um mehr Verständnis für die Biologie dieses Virus zu erlangen. Dennoch konnten
bisher weder ein Impfstoff noch eine das Virus vollständig eliminierende Therapie entwickelt
werden. Das Verständnis des viralen Lebenskreislaufs auf der einen Seite und des
Zusammenspiels von Gastzelle und Pathogen auf der anderen Seite ist eine grundlegende
Vorraussetzung für die Entwicklung neuer antiviraler Strategien.
Viren nutzen zelluläre Mechanismen für ihre eigene Replikation und Vermehrung. Eine
ausserordentliche Fähigkeit von Lentiviren ist der aktive Transport ihres
Präintegrationskomplexes (PIC) durch die intakte Kernmembran. Die molekulare Grundlage
dieses Vorgangs ist bis heute noch nicht bekannt. Im Falle von HIV gibt es allerdings
Hinweise, dass das akzessorische virale Protein R (Vpr) eine Rolle bei diesem Vorgang spielt.
Das Protein begleitet den PIC bei seinem Weg durch das Zytoplasma bis zu dessen Kontakt
mit der Kernmembran. Vpr bindet an Komponenten des Kernporenkomplexes (NPC), und es
besteht die Möglichkeit, dass Vpr durch diese Wechselwirkung den Kerntransport des PICs
vermittelt.
Beim Transport viraler Partikel durch das Zytoplasma spielt das Zytoskelett eine maßgebliche
Rolle. In diesem Zusammenhang stellten wir fest, dass der Zellkern von einem Geflecht an
Actin umgeben ist und hoch dynamische Invaginationen der Kernmembran aufweist. Um
Actin in lebenden Zellen darzustellen, haben wir eine neue Methode entwickelt, die auf der
Verwendung einer fluoreszierenden Form von Cytochalasin D (CD-BODIPY) basiert. Diese
Droge bindet spezifisch an das schnell wachsende Ende (free-barbed-end) von
Actinfilamenten. Mit Hilfe dieses Systems konnten wir zeigen, dass die Kernmembran von
stark polymerisationsaktivem Actin umgeben ist, und dass dieses Actin tief in die
Invaginationen der Kernmembran hineinreicht. Ein den Zellkern umgebendes Actingeflecht
wurde bereits früher beschrieben, allerdings war die Bedeutung und Auswirkung auf die
Struktur des Zellkerns nicht bekannt. In dieser Arbeit konnten wir nun zeigen, dass isolierte
und aufgereinigte Kernmembranen in vitro ausreichen, um die Polymerisierung von Actin zu
initiieren. Dieser Vorgang beinhaltet sowohl die Bindung von Actin an die Kernmembran als
auch das Wachstum von Filamenten. Dementsprechend demonstrieren unsere Ergebnisse,
dass die Zellkernmembran per se in der Lage ist, dieses spezielle Actinreservoir zu
manipulieren. Das HI-Virus könnte nun durch die Bindung von Vpr an den NPC das
beschriebene zelluläre Phänomen ausnutzen, um durch eine lokal Induktion der
Polymerisierung von Actin die Kernmembran zu überwinden.
Des Weiteren, haben wir Peptid Nuklein Säuren (PNAs) auf ihre Fähigkeit als neuartige
antivirale Präparate hin untersucht. PNAs wurden erst kürzlich entwickelt und stellen dank
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ihrer hervorragenden biochemischen Misch-Eigenschaften eine neue und sehr
vielversprechende Möglichkeit dar, Genexpression spezifisch zu inhibieren. In dieser
Hinsicht haben wir eine Reihe von PNAs synthetisiert, die gegen essentielle Sequenzen im
Genom von HIV gerichtet sind, und haben ihre Wirksamkeit in einer Vielzahl von
Versuchsanordnungen untersucht. Hiermit konnten wir zeigen, dass virale Partikel an
Infektiosität verlieren, wenn sie in Anwesenheit von PNAs produziert werden. In einem
anderen viralen Versuchssystem konnten wir unter Verwendung von PNAs, die gegen die
Sequenzen des Glycoproteins des Borna Disease Virus (BDV) gerichtet sind, die
Notwendigkeit des Hüllproteins von BDV für den Infektionsprozess aufzeigen. Außerdem
konnte durch die PNA-Behandlung eine Ausbreitung des Virus in primären Neuronen
blockiert werden. Diese Ergebnisse qualifizieren PNAs sowohl als leistungsfähige Hilfsmittel
für die Grundlagenforschung als auch eine vielversprechende Möglichkeiten im Hinblick auf
den Einsatz als antivirale Therapeutika.
5.3 Résumé (français)
Le virus d'immunodéficience humaine (VIH) est responsable du syndrome
d'immunodéficience acquise (SIDA), et entraîne la dégénérescence du système immunitaire.
Plus de vingt ans de recherche intense n'ont pas permis de développer un vaccin ou des voies
thérapeutiques permettant de guérir les malades. L'étape fondamentale pour découvrir de
nouvelles stratégies antivirales reste la compréhension de la pathogénie du SIDA ainsi que les
mécanismes moléculaires de l’interaction du virus avec l'hôte.
Comme tous les virus, le VIH détourne les machineries cellulaires pour se répliquer et se
propager. Une caractéristique des lentivirus est le transport actif du complexe de pré-
intégration (PIC) dans le noyau de la cellule hôte. Le mécanisme de ce transport n'est pas
connu, mais une protéine accessoire du VIH, appelée Vpr (viral protein R) pourrait être
impliquée dans ce processus. En effect Vpr reste associée au PIC jusqu'à la translocation du
génome à travers la membrane nucléaire. Par ailleurs, il a été montré que Vpr est capable
d’intéragir avec le complexe du pore nucléaire (NPC). Cela laisse soupçonner que cette
interaction est à la base de l'import nucléaire du PIC. Il a également été montré que le
cytosquelette joue un rôle prépondérant dans le transport de particules virales. Dans cette
perspective, nous avons observé que la membrane nucléaire est entourée d'une enveloppe
d'actine périnucléaire et que la membrane forme des invaginations dynamiques. Nous avons
mis au point une nouvelle approche pour visualiser l'actine dans les cellules vivantes basée
sur l'utilisation d'un analogue fluorescent de la cytochalasine D, le CD-BODIPY. Ce composé
se fixe sur les extrémités barbées des fibres courtes d'actine (free-barbed-ends), ce qui nous a
permis de visualiser dans des cellules vivantes un réservoir d'actine qui polymérise autour de
l’enveloppe nucléaire ainsi que dans les invaginations de cette membrane. Alors que la
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présence de filaments d'actine périnucléaire a été décrite dans plusieurs types cellulaires, leur
rôle, notamment dans la plasticité de l'enveloppe nucléaire, n'est toujours pas compris. Nous
avons montré que des enveloppes nucléaires isolées suffisent à initier la polymérisation de
filaments d'actine in vitro, un phénomène qui requiert à la fois le recrutement de l'actine à la
surface de l'enveloppe nucléaire et la croissance des filaments. Nos résultats démontrent que
la dynamique de l'actine périnucléaire est orchestrée par l'enveloppe nucléaire elle-même.
C'est donc via la liaison de Vpr au NPC que le virus pourrait exploiter la présence de l'actine
comme stratégie pour pénétrer dans le noyau en dépit de la barrière que constitue l'enveloppe.
Par ailleurs, nous avons testé l'effet des acides nucléiques peptides (PNAs) sur l'infection du
virus à différents stades du cycle invasif. Les PNAs sont des molécules de conception récente
dont les caractéristiques permettent l’utilisation dans une nouvelle approche antisens. Nous
avons synthétisé une série de PNAs dirigés contre des séquences fonctionnellement cruciales
du génome du VIH et les avons testés en explorant différentes conditions. Nous avons montré
que l'infectivité des virions produits en présence de PNAs est considérablement réduite. Dans
un autre système viral, les PNAs dirigés contre le Borna Disease Virus (BDV) nous ont
permis de mettre en évidence le rôle de la glycoprotéine de surface (GP) lors de l'infection.
De plus, nous avons montré que ce traitement inhibe la propagation de l'infection dans des
cultures de neurones primaires. Les PNAs sont donc des outils moléculaires extrèmement
efficaces, et des candidats prometteurs pour de nouvelles thérapeutiques antivirales.
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Chemical synthesis of pseudoisocytosin
To get a stable triplex formation, pseudoisocytosine (ψiC or ‘J bases’) is more
favorable than cytosine in the Hoogsteen strand because the ‘J-base’ does not require
low pH for N3 ‘protonation’ (see chapter 1.2.1). Pseudoisocytosine is not available by
any supplier and in order to design triplex forming PNAs we had to synthesize this
particular nucleobase ourselves. The synthesis had to be done in three main steps. In
independent reactions the N-(2-aminoethyl) glycine backbone, the ‘J-base’ and the
protecting group (Bhoc) for the exocyclic nitrogen of the ‘J-base’ had to be
synthesized. Finally, all three molecules were meant to be coupled in the last
synthesis steps.
Synthesis of the backbone (Thomson et al., 1995)
To a vigorously stirred solution of ethylenediamine (1) (75ml, 1.13mol) in CH2Cl2
(500ml) at 0˚C t-butyl bromoactate (20.7ml, 0.13mol) in CH2Cl2 (100ml) was added
over 5 hours. The resulting mixture was allowed to warm slowly to room temperature
(RT) and then stirred overnight. The reaction mixture was washed with water (3 x
125ml), and the combined aqueous wash was back-extracted with CH2Cl2 (125ml).
Combined organic phases were dried over MgSO4 and filtered. This workup gave
tert-butyl N-(2-aminoethyl)glycinate (2) with a yield of 14.8g (65%). This material
was taken after verification by mass spectrometry on the next step without further
purification (m/z 175 (M+H)+).
The Fmoc group was installed on the primary amine selectively. The product (2)
(14.8g, 0.085mol) was dissolved in CH2Cl2 and diisopropylethylenamine (18.75ml,
0.11mol) was added with mechanical stirring. A solution of N-(9-fluorenylmethoxy
carbonyloxy)succinimide (36.25g, 0.11mol) in CH2Cl2 (200ml) was added dropwise
over 5 hours. The solution was stirred overnight, and then washed with 1N aq. HCl (5
x 100ml) and brine (1 x 100ml). The organic layer was dried (MgSO4) and partially
concentrated in vacuo (ca. 250ml). Cooling (-20˚C) overnight resulted in a precipitate,
which was collected by filtration and washed with CH2Cl2 until the filtrate was
colorless. The solids were dried in vacuo (60˚C) to give tert-butyl N-[2-(N-9-
fluorenylmethoxycarbonyl)aminoethyl] glycinate hydrochloride (3) with a yield of
6.65g (36%) (m/z 397 (M+H)+).
To obtain the free base (3) (4.76g, 0.01mol) was dissolved in CHCl3 washed with
aqueous saturated NaHCO3 (2 x 150ml), dried (MgSO4) and concentrated in vacuo.
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Figure 31: PNA backbone synthesis
Reagent (a) BrCH2CO2C(CH3)3, CH2Cl2; (b) DIEA, N-(9-fluorenylmethoxycarbonyloxy)-succinimide.
Pseudoisocytosine (Egholm et al., 1995)
Sodium methoxide (40.5g, 0.75mol) was suspended in dry ether (500ml) and stirred
under N2 at 0˚C. A mixture of dimethyl succinate (4) (65.4ml, 0.50mol) and methyl-
formiate (5) (123ml, 2mol) was added dropwise over 45 min. The reaction mixture
was stirred at 0˚C for 2 hours and then at RT overnight. Subsequently, the reaction
mixture was evaporated to a viscous brown residue, which was washed once with
petroleum ether and then dissolved in 3M HCl (160ml). The solution was then made
weakly acidic with concentrated HCl and extracted with dichloromethane (4 x
250ml). The organic phase was dried (MgSO4), filtered and evaporated under low
pressure. The resulting residue was distilled at 65˚C and 0,7mbar overnight, yielding
38.7g (57%) of a mixture of methyl α-formylsuccinate (6) and dimethyl succinate
(80:20) as a colorless oil. After verification of the product the mixture was used
directly in the following preparation (NMR (as described in literature); m/z 174
(M+H)+).
Figure 32: Step 1: Pseudoisocytosin
Reagent (a) sodium methoxid (CH3ONa). Reaction was done in CH2Cl2 under N2 atmosphere.
In the second step, sodium methoxide (41.9g, 0.78mol) was dissolved in 200ml
methanol, dried with magnesium overnight and distilled immediately before use.
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When sodium methoxide was completely dissolved, guanidine hydrochloride (49.4g,
0.52mol) (7) was added and the mixture was stirred for 10 min under nitrogen at RT.
Then, a solution of methyl α-formylsuccinate (30.0g, 0.2mol) (6) in dry methanol was
added. The reaction mixture was refluxed under nitrogen for 3 hours and then stirred
at RT overnight. Subsequently, the reaction mixture was filtered, and the filter cake
was washed once with methanol. The collected filtrate and wash fraction were
evaporated under reduced pressure. The resulting residue was dissolved in water
(80ml) and the solution was acidified with concentrated HCl to pH 4.2. The mixture
was again stirred at 0˚C then filtered, the precipitate washed once with water and then
freeze-dried leaving 13.54g (46%) of isocytosin-5-ylacetic acid (8) as a white solid
(m/z 169 (M+H)+). Then, thionylchloride (3.6ml, 0.05mol) was added to stirred
methanol (210ml) at –40˚C under nitrogen, followed by isocytosin-5-ylacetic acid (8)
(7.0g, 0.04mol) and the mixture was stirred at RT for 1 hour, at 60˚C for 3 hours and
overnight at RT. The reaction mixture was evaporated to dryness and the residue was
dissolved in saturated aqueous sodium bicarbonate (NaHCO3, 80ml) giving a foamy
precipitate. 4M HCl was added to pH 6.5 and the suspension was stirred at RT for 1
hour. The precipitate was collected by filtration, washed with water, recrystallized
from water and freeze-dried yielding 4g (53%) of methyl isocytosin-5-ylacetate as
white crystals (9) (NMR (as described in literature); m/z 184 (M+H)+).
Figure 33: Step 2: Pseudoisocytosin
Reagents: (b) sodium methoxid (NaOCH3), (c) thionylchloride (SOCl2)
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Bhoc synthesis (Hiskey and Adams, 1965)
A mixture containing benzhydrol (10) (9.21g, 0.05mol), pyrimidine (4.065ml,
0.05mol) and 15ml chloroform was cooled in an ice bath and treated dropwise over 30
minutes with 4.3ml methyl chlorothiolcarbonate (11) (5.3g, 0.05mol). The mixture
was stirred for 1.5 hours and allowed to warm to RT. Most of the chloroform was
removed in vacuo, the residue was dissolved in ether and the pyridine hydrochloride
removed by filtration. The ether solution was washed with water and saturated sodium
chloride solution and dried with MgSO4. The evaporation of the ether resulted in a
yellow liquid benzhydryl methylthiolcarbonate (12), which was dried over calcium
chloride. The crude benzhydryl methylthiolcarbonate (12) was dissolved in ether
(45ml), cooled and slowly treated dropwise over 1 hour with a solution of 85%
hydrazine hydrate (3.75ml, 0.05mol) in 42.25ml methanol. The mixture was stirred
for 1.5 hours at RT and then allowed to stand 5 hours at RT. The organic layer was
evaporated and dried over silicagel. The solid was recrystallized from ether yielding
in 3.9g (36%) of benzhydryloxycarbonylhydrazide (13) as a white solid and used
directly in the following preparation (m.p. 101-102˚C; NMR (as described in
literature)).
A mixture of (13) (3.9g, 0.02mol), 5.5ml acetic acid and 3ml of water was stirred
until solution was completed and then cooled to 0-5˚C. The solution was treated with
powdered sodium nitrite (1.37g, 0.02mol) added in portions. Solid azide began
precipitating during the NaNO2 addition. The mixture was poured into 80ml of water
and extracted with ether. The extract was washed with 200ml of 1M sodium
hydrocarbonate solution (NaHCO3) until the washes were alkaline. The extract was
then washed with saturated sodium chloride solution, dried and evaporated to a
yellow oil. Cooling the oil provided 3.4g (33%) of benzhydryl azidoformate (14) as a
pale yellow solid (m.p. 37-39˚C; NMR (as described in literature)).
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Figure 34: Benzhydryl azidoformate synthesis
Reagent (a) pyridine (C5H5N), (b) hydrazine hydrate (N2H4) and (c) sodium nitrite (NaNO2).
Coupling of thymin to the Fmoc protected backbone (Jones et al., 1973)
Thymine (12.5g, 0.1mol), potassium hydroxide (27.5g, 0.5mol) and chloroacetic acid
(18.75g, 0.2mol) were dissolved in water (250ml) and the solution boiled for 1 hour.
The solution was cooled and the pH was adjusted to 3.5. The resulting precipitate was
filtered off and recrystallized twice from water to give 1-carboxymethylthymine (15)
with a yield of 6.65g (36%) (m/z 185 (M+H)+)
The free base of (3) (7.8g, 0.02mol) was dissolved in DMF (100ml) then 1-carboxy
methylthymine (15) (4.8g, 0.03mol) was added and the mixture was stirred until the
substance was dissolved. EDC (4.8g, 0.03mol) was added in two equal portions over
30 minutes, and the mixture stirred overnight. The solution was concentrated in
vacuo, and water (200ml) was added to the resulting thick oil. The mixture was
shaken vigorously for several minutes to precipitate a fine white solid. The solids
were collected by filtration, stirred with water (200ml), filtered, washed with cold
water, and dried in vacuo. Purification by flash chromatography (5% MeOH/CH2Cl2)
gave t e r t-butyl N-[2-(N-9-fluorenylmethoxycarbonyl)aminoethyl]-N-[(thymin-1-
yl)acetyl]glycinate (16) with a yield of 6.8g (66%). To a suspension of (16) (4.5g,
7.9mol) in anhyd CH2Cl2 (40ml) was added 4N HCl (4ml) in 1,4-dioxane (60ml) and
the mixture was stirred overnight. The solid was collected by filtration, washed with
hexane and dried in vacuo to give N-[2-(N-9-fluorenylmethoxycarbonyl)aminoethyl]-
N-[(thymin-1-yl)acetyl]glycinate (17) with a yield of 0.85g (21%) (m/z 507 (M+H)+)
(Thomson et al., 1995). The final product (the T-PNA-monomer) was used for the
PNA synthesis on the automated synthesizer Syro II (chapter 2.1).
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Figure 35: Coupling of thymin to the backbone
Reagents: (a) EDC (1-ethyl-3-(3-dimethylaminopropyl) carbodiimide) and the free base of (3) (b) HCl/
1,4-dioxane.
Coupling of methyl isocytosin-5-ylacetate to Bhoc protecting group (Hiskey
and Adams, 1965)
Finally we wanted to introduce the Bhoc protecting group on the exocyclic nitrogen
of methyl isocytosin-5-ylacetate. Therefore benzhydryl azidoformate (14) (3.4g,
0.007mol), methyl isocytosin-5-ylacetate (1.34g, 0.007mol) and magnesium oxide
(0.54g, 0.013mol) were mixed in 15ml of water and 30ml of dioxane and shaken for
~60 hours. The filtrated solution was diluted with 150ml of water and extracted with
ethyl acetate (3 x 80ml). The aqueous layer was cooled to 0˚C, acidified to pH 1-2
with 4N HCl and again extracted with ethyl acetate (3 x 80ml). The extract was
washed with water (3 x 100ml) and saturated sodium chloride solution (1 x 100ml),
dried with MgSO4 and evaporated to a pale yellow oil.
Figure 36: Introduction of the protecting group (Bhoc)
Reagents: (a) magnesium oxide (MgO)
N
N
H
O
O
CH3
CH2CO2H
O
N
H
N
O
C(CH3)3
Fmoc
N
O
N
CH3
O
O
H
O
N
H
N
O
Fmoc
N
O
N
CH3
O
O
H
H
a b
(15) (16) (17)
O
O
N N N
N N
H
O
O
O
COOMe
NH
N N
NH2
H
O
COOMe
a
+
(9)(14) (18)
Annex
120
The product (18) should have crystallized from a n-pentan/ ether mixture after the
reaction was completed. But unfortunately, no crystals were arising from the solution.
Even after further purification with chromatography (10% MeOH/CH2Cl2) the correct
product was not obtained (checked by mass spectrometry and NMR). The synthesis
was stopped at this point, because it became clear that the PNA approach to inhibit
the replicative cycle of HIV would not be further considered.
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CD-BODIPY labeling of a motile living cell
Figure 37: CD-BODIPY labeling of a U87 glioblastoma cell
The panel shows a bright field image of a migrating U87 glioblastoma cell displaying strong membrane
ruffling, and the corresponding fluorescence image showing the partitioning of CD-BODIPY (50nM)
into the membrane ruffles of the lamellipodia. In addition, high levels of CD-BODIPY are observed
around the nucleus. Note: the image is a montage of magnified fields comprising a mosaic across the
cell, and due to different intensities in different regions individual frames have been contrast adjusted
to accommodate different intensity levels (scale bar: 24µm).
Tracking of single NPCs of Vpr-expressing cells in vivo
To quantify membrane ruffling in Vpr expressing cells, we performed a series of in
vivo experiments imaging the punctuated pattern of the NPCs. For this purpose HeLa
cells were transfected with Vpr-GFP or a control plasmid. Approximately 5-6 hours
later, 4D image sequences of single nuclei were acquired (one z-stacks every ~15-30
minutes). We were using an imaging system most appropriate for in vivo fluorescence
microscopy, with fast acquisition time and a high power objective. The series of
images were then deconvolved and reconstructed for further analysis to track single
NPCs in the global context of the nuclear envelope.
Due to the small size of single NPCs (~7 nm in width and 50 nm in length) the
tracking is a very challenging project. Using any light-based microscopy, the best
objectives available offer planar (x,y) resolution in the range of ~200 nm. This means
that we are no longer able to spatially distinguish (resolve) two points closer than this
distance (the so-called ‘diffraction limit’). But fluorescent light of a subresolutional
point is emanating into focal planes above and underneath and can be collected by the
objective and projected to the light detector, a CCD (charge-coupled device) camera.
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The light from the sample is a highly complex representation of the subresolution
point inside the sampling voxel volume. Therefore even a subresolution object, such
as single NPC, can in fact be detected by its fluorescence (for review see (Roux et al.,
2004)).
After deconvolution and reconstruction, the movement of single spots, corresponding
to NPCs, was analyzed with an automated algorithm (developed by A. Genovesio).
To obtain useful results, the fluorescence of the spots must be strong and stable over
time. The preliminary result of the tracking of single NPCs is shown in Figure 38.
Figure 38: Tracking of single NPCs of a HeLa cell expressing Vpr-GFP
HeLa cells were transfected with a plasmid containing Vpr-GFP. About 6 hours after transfection 4D
image series were recorded and subsequent processed for the tracking of single NPCs. The program
was engendered to track single points through the volume and timeframe. The colored squares indicate
the NPCs recognized as single points by the algorithm of the tracking program.
These first experiments are very encouraging, but in order to have statistically reliable
data a certain amount of single nuclei have to be recorded and analyzed.
Visualization strategy of viral particles
To visualize HIV PICs in vivo, Annette Boese, a postdoc in the laboratory in Paris
(BCN, Pasteur Institute) has engineered GFP labeled viral particles. She constructed
an expression vector encoding a fusion protein from GFP-lacI and Vpr, both joined by
a peptide that represents the cleavage site for the HIV-1 protease (named pGFP-lacI-
HCS-Vpr). This fusion protein is co-expressed during particle production,
incorporated into the budding particle via the Vpr moiety and cleaved during
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maturation into the Vpr protein (that can subsequently exert its viral functions as it
lacks any tags) and GFP-lacI. GFP-lacI binds the lacO-repeats in the retroviral
genome after completion of reverse transcription to label the PIC until the site of
integration into the genome.
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